Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
achondrogenesis type II | COL2A1* | Col2a1* | 1 model | Alliance of Genome Resources | |||
adult-onset autosomal dominant demyelinating leukodystrophy | LMNB1* | Lmnb1* | 1 model | Alliance of Genome Resources | |||
advanced sleep phase syndrome 1 | PER2* | Per2* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 12 | CX3CR1* | Cx3cr1* | 2 models | Alliance of Genome Resources | |||
age related macular degeneration 4 | CFH* | Cfh*, Cfhr4 | 1 model | Alliance of Genome Resources | |||
Alexander disease | GFAP* | Gfap* | 4 models | Alliance of Genome Resources | |||
Alzheimer's disease 3 | PSEN1* | Psen1* | 6 models | Alliance of Genome Resources | |||
amelogenesis imperfecta type 1B | ENAM* | Enam* | 6 models | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD1* | Sod1* | 2 models | Alliance of Genome Resources | |||
ankyloblepharon-ectodermal defects-cleft lip/palate syndrome | TP63* | Trp63* | 1 model | Alliance of Genome Resources | |||
ankyrin-B-related cardiac arrhythmia | ANK2* | Ank2* | 1 model | Alliance of Genome Resources | |||
antithrombin III deficiency | SERPINC1* | Serpinc1* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 10 | DSG2* | Dsg2* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 12 | JUP* | Jup* | 4 models | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 8 | DSP* | Dsp* | 1 model | Alliance of Genome Resources | |||
atrial heart septal defect 2 | GATA4* | Gata4* | 1 model | Alliance of Genome Resources | |||
atrial heart septal defect 7 | NKX2-5* | Nkx2-5* | 2 models | Alliance of Genome Resources | |||
autoimmune interstitial lung, joint, and kidney disease | COPA* | Copa* | 1 model | Alliance of Genome Resources | |||
autosomal dominant auditory neuropathy 1 | DIAPH3* | Diaph3* | 2 models | Alliance of Genome Resources | |||
autosomal dominant congenital deafness with onychodystrophy | ATP6V1B2* | Atp6v1b2* | 2 models | Alliance of Genome Resources | |||
autosomal dominant distal hereditary motor neuronopathy 2 | HSPB8* | Hspb8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant familial periodic fever | TNFRSF1A* | Tnfrsf1a* | 3 models | Alliance of Genome Resources | |||
autosomal dominant hypocalcemia 1 | CASR* | Casr* | 2 models | Alliance of Genome Resources | |||
autosomal dominant hypocalcemia 2 | GNA11* | Gna11* | 2 models | Alliance of Genome Resources | |||
autosomal dominant hypophosphatemic rickets | FGF23* | Fgf23* | 2 models | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 26 | AUTS2* | Auts2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 38 | EEF1A2* | Eef1a2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 39 | MYT1L* | Myt1l* | 2 models | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder 7 | DYRK1A* | Dyrk1a* | 1 model | Alliance of Genome Resources | |||
autosomal dominant keratitis-ichthyosis-deafness syndrome | GJB2* | Gjb2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 3 | CHRNB2* | Chrnb2* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 12 | TECTA* | Tecta* | 4 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 13 | COL11A2* | Col11a2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 22 | MYO6* | Myo6* | 2 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | SLC17A8* | Slc17a8* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 36 | TMC1* | Tmc1* | 3 models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 41 | P2RX2* | P2rx2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 67 | OSBPL2* | Osbpl2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 9 | COCH* | Coch* | 1 model | Alliance of Genome Resources | |||
autosomal dominant osteopetrosis 2 | CLCN7* | Clcn7* | 7 models | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | PKD2* | Pkd2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant pseudohypoaldosteronism type 1 | NR3C2* | Nr3c2* | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | PITX2* | Pitx2* | 6 models | Alliance of Genome Resources | |||
Bannayan-Riley-Ruvalcaba syndrome | PTEN* | Pten* | 3 models | Alliance of Genome Resources | |||
Beare-Stevenson cutis gyrata syndrome | FGFR2* | Fgfr2* | 1 model | Alliance of Genome Resources | |||
Birt-Hogg-Dube syndrome | FLCN* | Flcn* | 2 models | Alliance of Genome Resources | |||
Bosch-Boonstra-Schaaf optic atrophy syndrome | NR2F1* | Nr2f1* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1 | IHH* | Ihh* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A2 | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brain small vessel disease 1 | COL4A1* | Col4a1* | 1 model | Alliance of Genome Resources | |||
branchiootorenal syndrome | SIX1* | Six1* | 1 model | Alliance of Genome Resources | |||
branchiootorenal syndrome | EYA1* | Eya1* | 4 models | Alliance of Genome Resources | |||
Brugada syndrome 1 | SCN5A* | Scn5a* | 2 models | Alliance of Genome Resources | |||
Brugada syndrome 7 | SCN3B* | Scn3b* | 1 model | Alliance of Genome Resources | |||
bullous congenital ichthyosiform erythroderma | KRT2* | Krt2* | 2 models | Alliance of Genome Resources | |||
CADASIL 1 | NOTCH3* | Notch3* | 6 models | Alliance of Genome Resources | |||
campomelic dysplasia | SOX9* | Sox9* | 9 models | Alliance of Genome Resources | |||
Carney complex | PRKAR1A* | Prkar1a* | 4 models | Alliance of Genome Resources | |||
cataract 10 multiple types | CRYBA1* | Cryba1* | 2 models | Alliance of Genome Resources | |||
cataract 14 multiple types | GJA3* | Gja3* | 2 models | Alliance of Genome Resources | |||
cataract 15 multiple types | MIP* | Mip* | 7 models | Alliance of Genome Resources | |||
cataract 16 multiple types | CRYAB* | Cryab* | 1 model | Alliance of Genome Resources | |||
cataract 1 multiple types | GJA8* | Gja8* | 4 models | Alliance of Genome Resources | |||
cataract 20 multiple types | CRYGS* | Crygs* | 3 models | Alliance of Genome Resources | |||
cataract 21 multiple types | MAF* | Maf* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGC* | Crygc* | 2 models | Alliance of Genome Resources | |||
cataract 30 | VIM* | Vim* | 1 model | Alliance of Genome Resources | |||
cataract 39 multiple types | CRYGB* | Crygb* | 6 models | Alliance of Genome Resources | |||
cataract 3 multiple types | CRYBB2* | Crybb2* | 3 models | Alliance of Genome Resources | |||
cataract 4 multiple types | CRYGD* | Crygd*, Cryge, Crygf | 2 models | Alliance of Genome Resources | |||
cataract 5 multiple types | HSF4* | Hsf4* | 2 models | Alliance of Genome Resources | |||
cataract 6 multiple types | EPHA2* | Epha2* | 1 model | Alliance of Genome Resources | |||
cataract 9 multiple types | CRYAA* | Cryaa* | 9 models | Alliance of Genome Resources | |||
central precocious puberty 2 | MKRN3* | Mkrn3* | 1 model | Alliance of Genome Resources | |||
cerebellar ataxia type 42 | CACNA1G* | Cacna1g* | 2 models | Alliance of Genome Resources | |||
cerebrocostomandibular syndrome | SNRPB* | Snrpb* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2K | GDAP1* | Gdap1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2O | DYNC1H1* | Dync1h1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2P | LRSAM1* | Lrsam1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Q | DHTKD1* | Dhtkd1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Z | MORC2* | Morc2a*, Morc2b | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease dominant intermediate C | YARS1* | Yars1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1A | PMP22* | Pmp22* | 6 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1B | MPZ* | Mpz* | 10 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1C | LITAF* | Litaf* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1E | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A1 | KIF1B* | Kif1b* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A2A | MFN2* | Mfn2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B | RAB7A* | Rab7* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2D | GARS1* | Gars1* | 4 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2E | NEFL* | Nefl* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | MPZ* | Mpz* | 3 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4E | EGR2* | Egr2* | 2 models | Alliance of Genome Resources | |||
cherubism | SH3BP2* | Sh3bp2* | 2 models | Alliance of Genome Resources | |||
CINCA Syndrome | NLRP3* | Nlrp3* | 1 model | Alliance of Genome Resources | |||
cleidocranial dysplasia | RUNX2* | Runx2* | 4 models | Alliance of Genome Resources | |||
Clouston syndrome | GJB6* | Gjb6* | 1 model | Alliance of Genome Resources | |||
Coffin-Siris syndrome 1 | ARID1B* | Arid1b* | 1 model | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 4 | TUBG1* | Tubg1* | 1 model | Alliance of Genome Resources | |||
complex cortical dysplasia with other brain malformations 7 | TUBB2B* | Tubb2b* | 1 model | Alliance of Genome Resources | |||
congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | PBX1* | Pbx1* | 1 model | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | PHOX2B* | Phox2b* | 2 models | Alliance of Genome Resources | |||
congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | CDK13* | Cdk13* | 1 model | Alliance of Genome Resources | |||
congenital megabladder | MYOCD* | Myocd* | 2 models | Alliance of Genome Resources | |||
congenital muscular dystrophy due to LMNA mutation | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 3A | CHRND* | Chrnd* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4A | CHRNE* | Chrne* | 2 models | Alliance of Genome Resources | |||
congenital myopathy 1A | RYR1* | Ryr1* | 3 models | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 1 | RHO* | Rho* | 1 model | Alliance of Genome Resources | |||
congenital stationary night blindness autosomal dominant 2 | PDE6B* | Pde6b* | 14 models | Alliance of Genome Resources | |||
Cornelia de Lange syndrome 1 | NIPBL* | Nipbl* | 2 models | Alliance of Genome Resources | |||
Cornelia de Lange syndrome 3 | SMC3* | Smc3* | 1 model | Alliance of Genome Resources | |||
cortisone reductase deficiency 2 | HSD11B1* | Hsd11b1* | 1 model | Alliance of Genome Resources | |||
Costello syndrome | HRAS* | Hras* | 2 models | Alliance of Genome Resources | |||
dentinogenesis imperfecta | DSPP* | Dspp* | 1 model | Alliance of Genome Resources | |||
Denys-Drash syndrome | WT1* | Wt1* | 6 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 14 | KCNT1* | Kcnt1* | 2 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 17 | GNAO1* | Gnao1* | 3 models | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 54 | HNRNPU* | Hnrnpu* | 1 model | Alliance of Genome Resources | |||
developmental and epileptic encephalopathy 7 | KCNQ2* | Kcnq2* | 1 model | Alliance of Genome Resources | |||
Diamond-Blackfan anemia 6 | RPL5* | Rpl5* | 1 model | Alliance of Genome Resources | |||
Diamond-Blackfan anemia 7 | RPL11* | Rpl11* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | TBX1* | Tbx1* | 23 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1A | LMNA* | Lmna* | 4 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1C | LDB3* | Ldb3* | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1CC | NEXN* | Nexn* | 4 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1D | TNNT2* | Tnnt2* | 3 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1DD | RBM20* | Rbm20* | 3 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1HH | BAG3* | Bag3* | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1R | ACTC1* | Actc1* | 1 model | Alliance of Genome Resources | |||
dilated cardiomyopathy 1Y | TPM1* | Tpm1* | 2 models | Alliance of Genome Resources | |||
Doyne honeycomb retinal dystrophy | EFEMP1* | Efemp1* | 4 models | Alliance of Genome Resources | |||
Dravet syndrome | SCN1A* | Scn1a* | 8 models | Alliance of Genome Resources | |||
Duane-radial ray syndrome | SALL4* | Sall4* | 4 models | Alliance of Genome Resources | |||
ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 | TP63* | Trp63* | 4 models | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A1* | Col5a1* | 3 models | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Ogna type | PLEC* | Plec* | 4 models | Alliance of Genome Resources | |||
episodic kinesigenic dyskinesia 1 | PRRT2* | Prrt2* | 2 models | Alliance of Genome Resources | |||
familial cold autoinflammatory syndrome 1 | NLRP3* | Nlrp3* | 2 models | Alliance of Genome Resources | |||
familial cold autoinflammatory syndrome 4 | NLRC4* | Nlrc4* | 1 model | Alliance of Genome Resources | |||
familial encephalopathy with neuroserpin inclusion bodies | SERPINI1* | Serpini1* | 1 model | Alliance of Genome Resources | |||
familial episodic pain syndrome 3 | SCN11A* | Scn11a* | 1 model | Alliance of Genome Resources | |||
familial hyperinsulinemic hypoglycemia 3 | GCK* | Gck* | 1 model | Alliance of Genome Resources | |||
familial hypocalciuric hypercalcemia 1 | CASR* | Casr* | 7 models | Alliance of Genome Resources | |||
familial temporal lobe epilepsy 1 | LGI1* | Lgi1* | 4 models | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | ACVR1* | Acvr1* | 5 models | Alliance of Genome Resources | |||
focal segmental glomerulosclerosis 1 | ACTN4* | Actn4* | 1 model | Alliance of Genome Resources | |||
focal segmental glomerulosclerosis 2 | TRPC6* | Trpc6* | 3 models | Alliance of Genome Resources | |||
GAND syndrome | GATAD2B* | Gatad2b* | 1 model | Alliance of Genome Resources | |||
gnathodiaphyseal dysplasia | ANO5* | Ano5* | 2 models | Alliance of Genome Resources | |||
Greig cephalopolysyndactyly syndrome | GLI3* | Gli3* | 1 model | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | GRN* | Grn* | 3 models | Alliance of Genome Resources | |||
Hajdu-Cheney syndrome | NOTCH2* | Notch2* | 4 models | Alliance of Genome Resources | |||
hand-foot-genital syndrome | HOXA13* | Hoxa13* | 5 models | Alliance of Genome Resources | |||
hereditary hemorrhagic telangiectasia | ENG* | Eng* | 6 models | Alliance of Genome Resources | |||
hereditary hemorrhagic telangiectasia | ACVRL1* | Acvrl1* | 5 models | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT1* | Ext1* | 5 models | Alliance of Genome Resources | |||
hereditary neuropathy with liability to pressure palsies | PMP22* | Pmp22* | 3 models | Alliance of Genome Resources | |||
hereditary neutrophilia | CSF3R* | Csf3r* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 13 | HSPD1* | Hspd1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 31 | REEP1* | Reep1* | 1 model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 4 | SPAST* | Spast* | 3 models | Alliance of Genome Resources | |||
hereditary spastic paraplegia 80 | UBAP1* | Ubap1* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | ANK1* | Ank1* | 4 models | Alliance of Genome Resources | |||
holoprosencephaly 11 | CDON* | Cdon* | 8 models | Alliance of Genome Resources | |||
holoprosencephaly 2 | SIX3* | Six3* | 4 models | Alliance of Genome Resources | |||
holoprosencephaly 3 | SHH* | Shh* | 3 models | Alliance of Genome Resources | |||
holoprosencephaly 5 | ZIC2* | Zic2* | 3 models | Alliance of Genome Resources | |||
Holt-Oram syndrome | TBX5* | Tbx5* | 3 models | Alliance of Genome Resources | |||
hyperekplexia 1 | GLRA1* | Glra1* | 4 models | Alliance of Genome Resources | |||
hyperekplexia 3 | SLC6A5* | Slc6a5* | 2 models | Alliance of Genome Resources | |||
hyper IgE recurrent infection syndrome 1 | STAT3* | Stat3* | 1 model | Alliance of Genome Resources | |||
hypochondroplasia | FGFR3* | Fgfr3* | 1 model | Alliance of Genome Resources | |||
hypomyelinating leukodystrophy 6 | TUBB4A* | Tubb4a* | 3 models | Alliance of Genome Resources | |||
hypotrichosis 13 | KRT71* | Krt71* | 1 model | Alliance of Genome Resources | |||
immunodeficiency 15A | IKBKB* | Ikbkb* | 2 models | Alliance of Genome Resources | |||
immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia | RAC2* | Rac2* | 1 model | Alliance of Genome Resources | |||
isolated mitochondrial myopathy | CHCHD10* | Chchd10* | 1 model | Alliance of Genome Resources | |||
juvenile polyposis syndrome | BMPR1A* | Bmpr1a* | 1 model | Alliance of Genome Resources | |||
juvenile polyposis syndrome | SMAD4* | Smad4* | 1 model | Alliance of Genome Resources | |||
KINSSHIP syndrome | AFF3* | Aff3* | 1 model | Alliance of Genome Resources | |||
Kleefstra syndrome 1 | EHMT1* | Ehmt1* | 2 models | Alliance of Genome Resources | |||
Koolen de Vries syndrome | KANSL1* | Kansl1* | 1 model | Alliance of Genome Resources | |||
Li-Fraumeni syndrome | TP53* | Trp53* | 8 models | Alliance of Genome Resources | |||
long QT syndrome 1 | KCNQ1* | Kcnq1* | 1 model | Alliance of Genome Resources | |||
long QT syndrome 3 | SCN5A* | Scn5a* | 4 models | Alliance of Genome Resources | |||
Lynch syndrome | MSH2* | Msh2* | 5 models | Alliance of Genome Resources | |||
Lynch syndrome | MLH1* | Mlh1* | 2 models | Alliance of Genome Resources | |||
macrocephaly-autism syndrome | PTEN* | Pten* | 2 models | Alliance of Genome Resources | |||
malignant hyperthermia | RYR1* | Ryr1* | 5 models | Alliance of Genome Resources | |||
Marsili syndrome | ZFHX2* | Zfhx2* | 2 models | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 1 | HNF4A* | Hnf4a* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 2 | GCK* | Gck* | 29 models | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 3 | HNF1A* | Hnf1a* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young type 4 | PDX1* | Pdx1* | 1 model | Alliance of Genome Resources | |||
mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations | MAST1* | Mast1* | 1 model | Alliance of Genome Resources | |||
Mowat-Wilson syndrome | ZEB2* | Zeb2* | 1 model | Alliance of Genome Resources | |||
Muenke Syndrome | FGFR3* | Fgfr3* | 6 models | Alliance of Genome Resources | |||
multicentric carpotarsal osteolysis syndrome | MAFB* | Mafb* | 1 model | Alliance of Genome Resources | |||
multiple endocrine neoplasia type 1 | MEN1* | Men1* | 7 models | Alliance of Genome Resources | |||
multiple endocrine neoplasia type 2B | RET* | Ret* | 2 models | Alliance of Genome Resources | |||
multiple epiphyseal dysplasia 5 | MATN3* | Matn3* | 1 model | Alliance of Genome Resources | |||
myoclonic dystonia 11 | SGCE* | Sgce* | 2 models | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | DES* | Des* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 2 | CRYAB* | Cryab* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 5 | FLNC* | Flnc* | 1 model | Alliance of Genome Resources | |||
nail-patella syndrome | LMX1B* | Lmx1b* | 4 models | Alliance of Genome Resources | |||
nemaline myopathy 6 | KBTBD13* | Kbtbd13* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | BPTF* | Bptf* | 1 model | Alliance of Genome Resources | |||
neurodevelopmental disorder with involuntary movements | GNAO1* | Gnao1* | 1 model | Alliance of Genome Resources | |||
neurofibromatosis 1 | NF1* | Nf1* | 17 models | Alliance of Genome Resources | |||
neurohypophyseal diabetes insipidus | AVP* | Avp* | 2 models | Alliance of Genome Resources | |||
Noonan syndrome 1 | PTPN11* | Ptpn11* | 3 models | Alliance of Genome Resources | |||
Noonan syndrome 10 | LZTR1* | Lztr1* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome 3 | KRAS* | Kras* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome 4 | SOS1* | Sos1* | 2 models | Alliance of Genome Resources | |||
Noonan syndrome 5 | RAF1* | Raf1* | 2 models | Alliance of Genome Resources | |||
Noonan syndrome 8 | RIT1* | Rit1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 1 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | COL1A1* | Col1a1* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A2* | Col1a2* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 4 | COL1A1* | Col1a1* | 3 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | IFITM5* | Ifitm5* | 1 model | Alliance of Genome Resources | |||
pachyonychia congenita | KRT16* | Krt16* | 1 model | Alliance of Genome Resources | |||
Pallister-Hall syndrome | GLI3* | Gli3* | 1 model | Alliance of Genome Resources | |||
palmoplantar keratoderma-esophageal carcinoma syndrome | RHBDF2* | Rhbdf2* | 3 models | Alliance of Genome Resources | |||
Parkinson's disease 1 | SNCA* | Snca* | 6 models | Alliance of Genome Resources | |||
Parkinson's disease 17 | VPS35* | Vps35* | 2 models | Alliance of Genome Resources | |||
Parkinson's disease 4 | SNCA* | Snca* | 1 model | Alliance of Genome Resources | |||
Parkinson's disease 8 | LRRK2* | Lrrk2* | 1 model | Alliance of Genome Resources | |||
paroxysmal nonkinesigenic dyskinesia 1 | PNKD* | Pnkd* | 2 models | Alliance of Genome Resources | |||
PCWH syndrome | SOX10* | Sox10* | 1 model | Alliance of Genome Resources | |||
Pelger-Huet anomaly | LBR* | Lbr* | 1 model | Alliance of Genome Resources | |||
permanent neonatal diabetes mellitus | KCNJ11* | Kcnj11* | 3 models | Alliance of Genome Resources | |||
permanent neonatal diabetes mellitus | INS* | Ins2*, Ins1 | 1 model | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR2* | Fgfr2* | 1 model | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR1* | Fgfr1* | 2 models | Alliance of Genome Resources | |||
piebaldism | KIT* | Kit* | 1 model | Alliance of Genome Resources | |||
Pierpont syndrome | TBL1XR1* | Tbl1xr1* | 1 model | Alliance of Genome Resources | |||
Pitt-Hopkins syndrome | TCF4* | Tcf4* | 6 models | Alliance of Genome Resources | |||
platelet-type bleeding disorder 16 | ITGA2B* | Itga2b* | 1 model | Alliance of Genome Resources | |||
platelet-type bleeding disorder 16 | ITGB3* | Itgb3* | 1 model | Alliance of Genome Resources | |||
polycystic kidney disease 1 | PKD1* | Pkd1* | 27 models | Alliance of Genome Resources | |||
polycystic kidney disease 2 | PKD2* | Pkd2* | 7 models | Alliance of Genome Resources | |||
popliteal pterygium syndrome | IRF6* | Irf6* | 2 models | Alliance of Genome Resources | |||
progeria | LMNA* | Lmna* | 14 models | Alliance of Genome Resources | |||
progressive familial heart block type IA | SCN5A* | Scn5a* | 2 models | Alliance of Genome Resources | |||
pseudoachondroplasia | COMP* | Comp* | 2 models | Alliance of Genome Resources | |||
renal coloboma syndrome | PAX2* | Pax2* | 6 models | Alliance of Genome Resources | |||
retinitis pigmentosa 1 | RP1* | Rp1* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 11 | PRPF31* | Prpf31* | 1 model | Alliance of Genome Resources | |||
retinitis pigmentosa 13 | PRPF8* | Prpf8* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 18 | PRPF3* | Prpf3* | 2 models | Alliance of Genome Resources | |||
retinitis pigmentosa 4 | RHO* | Rho* | 13 models | Alliance of Genome Resources | |||
retinitis pigmentosa 7 | PRPH2* | Prph2* | 3 models | Alliance of Genome Resources | |||
rippling muscle disease 2 | CAV3* | Cav3* | 3 models | Alliance of Genome Resources | |||
Rubinstein-Taybi syndrome | CREBBP* | Crebbp* | 4 models | Alliance of Genome Resources | |||
Saethre-Chotzen syndrome | TWIST1* | Twist1* | 8 models | Alliance of Genome Resources | |||
scalp-ear-nipple syndrome | KCTD1* | Kctd1* | 2 models | Alliance of Genome Resources | |||
Schnyder corneal dystrophy | UBIAD1* | Ubiad1* | 2 models | Alliance of Genome Resources | |||
sclerosteosis 2 | LRP4* | Lrp4* | 2 models | Alliance of Genome Resources | |||
SHORT syndrome | PIK3R1* | Pik3r1* | 1 model | Alliance of Genome Resources | |||
Sorsby's fundus dystrophy | TIMP3* | Timp3* | 2 models | Alliance of Genome Resources | |||
Sotos syndrome 2 | NFIX* | Nfix* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 1 | ATXN1* | Atxn1* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 14 | PRKCG* | Prkcg* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 17 | TBP* | Tbp* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 2 | ATXN2* | Atxn2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 28 | AFG3L2* | Afg3l2* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 5 | SPTBN2* | Sptbn2* | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 6 | CACNA1A* | Cacna1a* | 3 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 7 | ATXN7* | Atxn7* | 5 models | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX5* | Dlx5* | 2 models | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | COL2A1* | Col2a1* | 7 models | Alliance of Genome Resources | |||
STING-associated vasculopathy with onset in infancy | STING1* | Sting1* | 1 model | Alliance of Genome Resources | |||
Stormorken syndrome | STIM1* | Stim1* | 1 model | Alliance of Genome Resources | |||
Teebi hypertelorism syndrome 1 | SPECC1L* | Specc1l* | 2 models | Alliance of Genome Resources | |||
tibial muscular dystrophy | TTN* | Ttn* | 1 model | Alliance of Genome Resources | |||
Tietz syndrome | MITF* | Mitf* | 14 models | Alliance of Genome Resources | |||
Timothy syndrome | CACNA1C* | Cacna1c* | 1 model | Alliance of Genome Resources | |||
torsion dystonia 1 | TOR1A* | Tor1a* | 4 models | Alliance of Genome Resources | |||
torsion dystonia 6 | THAP1* | Thap1* | 2 models | Alliance of Genome Resources | |||
Townes-Brocks syndrome | SALL1* | Sall1* | 3 models | Alliance of Genome Resources | |||
transthyretin amyloidosis | TTR* | Ttr* | 4 models | Alliance of Genome Resources | |||
Treacher Collins syndrome | TCOF1* | Tcof1* | 2 models | Alliance of Genome Resources | |||
trichorhinophalangeal syndrome type I | TRPS1* | Trps1* | 1 model | Alliance of Genome Resources | |||
tuberous sclerosis | TSC1* | Tsc1* | 10 models | Alliance of Genome Resources | |||
tuberous sclerosis | TSC2* | Tsc2* | 9 models | Alliance of Genome Resources | |||
tubular aggregate myopathy 1 | STIM1* | Stim1* | 2 models | Alliance of Genome Resources | |||
ulnar-mammary syndrome | TBX3* | Tbx3* | 1 model | Alliance of Genome Resources | |||
vascular type Ehlers-Danlos syndrome | COL3A1* | Col3a1* | 2 models | Alliance of Genome Resources | |||
vestibular schwannomatosis | NF2* | Nf2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome type 1 | PAX3* | Pax3* | 6 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 2A | MITF* | Mitf* | 14 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4A | EDNRB* | Ednrb* | 2 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4B | EDN3* | Edn3* | 3 models | Alliance of Genome Resources | |||
Waardenburg syndrome type 4C | SOX10* | Sox10* | 1 model | Alliance of Genome Resources | |||
Weaver syndrome | EZH2* | Ezh2* | 3 models | Alliance of Genome Resources | |||
WHIM syndrome 1 | CXCR4* | Cxcr4* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | EIF4H* | Eif4h* | 3 models | Alliance of Genome Resources | |||
Xia-Gibbs Syndrome | AHDC1* | Ahdc1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | LEP | Lep* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | SIRT3 | Sirt3* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | PRKCI | Prkci* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | PPARG | Pparg* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | NEIL1 | Neil1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | GUCY2C | Gucy2c* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | CTF1 | Ctf1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome | SLC2A9 | Slc2a9* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome 1 | TP53INP1 | Trp53inp1* | 1 model | Alliance of Genome Resources | |||
abdominal obesity-metabolic syndrome 1 | LEP | Lep* | 3 models | Alliance of Genome Resources | |||
age related macular degeneration | CCL2, CCL13 | Ccl2*, Ccl12 | 3 models | Alliance of Genome Resources | |||
age related macular degeneration | CCR2 | Ccr2* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | CD46 | Cd46* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration | PPARGC1A | Ppargc1a* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | CRYBA1 | Cryba1* | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | VLDLR | Vldlr* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VPS54 | Vps54* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | VEGFA | Vegfa* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SOD2 | Sod2* | 1 model | Alliance of Genome Resources | |||
amyotrophic lateral sclerosis type 1 | SNCG | Sncg* | 1 model | Alliance of Genome Resources | |||
arrhythmogenic right ventricular dysplasia 5 | RPSA | Rpsa* | 1 model | Alliance of Genome Resources | |||
autosomal dominant disease | FGFR3 | Fgfr3* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | ZBTB18 | Zbtb18* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | MBD5 | Mbd5* | 1 model | Alliance of Genome Resources | |||
autosomal dominant intellectual developmental disorder | AUTS2 | Auts2* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 25 | TRPV4 | Trpv4* | 1 model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 4A | CEACAM16 | Ceacam16* | 1 model | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | BICC1 | Bicc1* | 1 model | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | NPHP3 | Nphp3* | 3 models | Alliance of Genome Resources | |||
autosomal dominant polycystic kidney disease | MYC | Myc*, Bmyc | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 1 | HMGN2 | Hmgn2*, Hmgn2-ps | 1 model | Alliance of Genome Resources | |||
Axenfeld-Rieger syndrome type 3 | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
cataract 2 multiple types | CRYGD | Crygd*, Cryge, Crygf | 1 model | Alliance of Genome Resources | |||
central conducting lymphatic anomaly | MDFIC | Mdfic* | 1 model | Alliance of Genome Resources | |||
cleidocranial dysplasia | Ccd* | 2 models | |||||
Coffin-Siris syndrome | ARID1A | Arid1a* | 2 models | Alliance of Genome Resources | |||
congenital central hypoventilation syndrome | TLX3 | Tlx3* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | b2b954Clo* | 1 model | |||||
DiGeorge syndrome | NDST1 | Ndst1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | ALDH1A2 | Aldh1a2* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | CHRD | Chrd* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | CRKL | Crkl* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | PLXND1 | Plxnd1* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | pta* | 1 model | |||||
DiGeorge syndrome | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | VEGFA | Vegfa* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | ZNF366 | Zfp366* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | KAT6A | Kat6a* | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | HOXA3 | Hoxa3* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | b2b1941Clo* | 1 model | |||||
DiGeorge syndrome | DICER1 | Dicer1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | DOCK1 | Dock1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | FGF8 | Fgf8* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | FOXN1 | Foxn1* | 1 model | Alliance of Genome Resources | |||
DiGeorge syndrome | b2b2696Clo* | 1 model | |||||
dilated cardiomyopathy 1A | DOT1L | Dot1l* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A2 | Col5a2* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | LUM | Lum* | 2 models | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Dowling-Meara type | KRT14 | Krt14* | 3 models | Alliance of Genome Resources | |||
epidermolysis bullosa simplex Dowling-Meara type | KRT5 | Krt5* | 1 model | Alliance of Genome Resources | |||
familial medullary thyroid carcinoma | PRLR | Prlr* | 1 model | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | TARDBP | Tardbp* | 1 model | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT2 | Ext2* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | ADD2 | Add2* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | SPTA1 | Spta1* | 3 models | Alliance of Genome Resources | |||
hereditary spherocytosis type 1 | EPB42 | Epb42* | 1 model | Alliance of Genome Resources | |||
hereditary spherocytosis type 4 | SLC4A1 | Slc4a1* | 1 model | Alliance of Genome Resources | |||
Holt-Oram syndrome | vsd* | 2 models | |||||
hypotrichosis 4 | HR | Hr* | 1 model | Alliance of Genome Resources | |||
ichthyosis vulgaris | LBR | Lbr* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | TNF | Tnf* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | FOSL2 | Fosl2* | 1 model | Alliance of Genome Resources | |||
juvenile glaucoma | PAX6 | Pax6* | 1 model | Alliance of Genome Resources | |||
lacrimoauriculodentodigital syndrome 1 | FGF10 | Fgf10* | 1 model | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFB2 | Tgfb2* | 2 models | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
Loeys-Dietz syndrome | TGFBR1 | Tgfbr1* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | TGM2 | Tgm2* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | MAFA | Mafa* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | PDX1 | Pdx1* | 1 model | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | INS | Ins2*, Ins1 | 3 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | PAFAH1B1 | Pafah1b1* | 5 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | HIC1 | Hic1* | 1 model | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | YWHAE | Ywhae* | 2 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | DPH1 | Dph1* | 3 models | Alliance of Genome Resources | |||
Miller-Dieker lissencephaly syndrome | MNT | Mnt* | 1 model | Alliance of Genome Resources | |||
Muir-Torre syndrome | FHIT | Fhit* | 1 model | Alliance of Genome Resources | |||
multiple synostoses syndrome | FGF9 | Fgf9* | 2 models | Alliance of Genome Resources | |||
multiple synostoses syndrome | GDF5 | Gdf5* | 1 model | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | LDB3 | Ldb3* | 1 model | Alliance of Genome Resources | |||
nail-patella syndrome | LDB1 | Ldb1* | 1 model | Alliance of Genome Resources | |||
Noonan syndrome with multiple lentigines | PTPN11 | Ptpn11* | 3 models | Alliance of Genome Resources | |||
ocular albinism with sensorineural deafness | MITF | Mitf* | 14 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | SUCO | Suco* | 1 model | Alliance of Genome Resources | |||
PCWH syndrome | MPZ | Mpz* | 1 model | Alliance of Genome Resources | |||
polycystic liver disease | UCP2 | Ucp2* | 1 model | Alliance of Genome Resources | |||
polycystic liver disease | PRKCSH | Prkcsh* | 1 model | Alliance of Genome Resources | |||
popliteal pterygium syndrome | RIPK4 | Ripk4* | 1 model | Alliance of Genome Resources | |||
progeria | ZMPSTE24 | Zmpste24* | 3 models | Alliance of Genome Resources | |||
progeria | VCPIP1 | Vcpip1* | 1 model | Alliance of Genome Resources | |||
progeria | SIRT6 | Sirt6* | 1 model | Alliance of Genome Resources | |||
spinocerebellar ataxia type 27 | FGF14 | Fgf14* | 1 model | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX6 | Dlx6* | 2 models | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | HAPLN1 | Hapln1* | 1 model | Alliance of Genome Resources | |||
Stargardt disease | ELOVL4 | Elovl4* | 2 models | Alliance of Genome Resources | |||
Stargardt disease | ABCA4 | Abca4* | 5 models | Alliance of Genome Resources | |||
type 1 diabetes mellitus 2 | IGF2 | Igf2* | 3 models | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A1 | Col6a1* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome | SNAI2 | Snai2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome | AEBP2 | Aebp2* | 1 model | Alliance of Genome Resources | |||
Waardenburg syndrome type 1 | MITF | Mitf* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FZD9 | Fzd9* | 4 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | DLG4 | Dlg4* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | b2b370Clo* | 1 model | |||||
Williams-Beuren syndrome | BAZ1B | Baz1b* | 6 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | SRC | Src* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | LOX | Lox* | 1 model | Alliance of Genome Resources | |||
Williams-Beuren syndrome | LIMK1 | Limk1* | 3 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | GTF2IRD1 | Gtf2ird1* | 6 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | GTF2I | Gtf2i* | 4 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | CLIP2 | Clip2* | 3 models | Alliance of Genome Resources | |||
3-methylglutaconic aciduria type 7a | CLPB* | Clpb | Alliance of Genome Resources | ||||
46,XX sex reversal 4 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
46,XX sex reversal 5 | NR2F2* | Nr2f2 | Alliance of Genome Resources | ||||
46,XY sex reversal 3 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
46,XY sex reversal 6 | MAP3K1* | Map3k1 | Alliance of Genome Resources | ||||
46,XY sex reversal 9 | ZFPM2* | Zfpm2 | Alliance of Genome Resources | ||||
abdominal obesity-metabolic syndrome 3 | DYRK1B* | Dyrk1b | Alliance of Genome Resources | ||||
abdominal obesity-metabolic syndrome 4 | CELA2A*, CELA2B | Cela2a | Alliance of Genome Resources | ||||
ablepharon macrostomia syndrome | TWIST2* | Twist2 | Alliance of Genome Resources | ||||
acrofacial dysostosis Cincinnati type | POLR1A* | Polr1a | Alliance of Genome Resources | ||||
acrokeratosis verruciformis | ATP2A2* | Atp2a2 | Alliance of Genome Resources | ||||
acromelic frontonasal dysostosis | ZSWIM6* | Zswim6 | Alliance of Genome Resources | ||||
adermatoglyphia | SMARCAD1* | Smarcad1 | Alliance of Genome Resources | ||||
adult-onset leukoencephalopathy with axonal spheroids and pigmented glia | CSF1R* | Csf1r | Alliance of Genome Resources | ||||
ADULT syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | PER2* | Per2 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | AANAT* | Aanat | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | PER3* | Per3 | Alliance of Genome Resources | ||||
advanced sleep phase syndrome | TIMELESS* | Timeless | Alliance of Genome Resources | ||||
advanced sleep phase syndrome 2 | CSNK1D* | Csnk1d | Alliance of Genome Resources | ||||
advanced sleep phase syndrome 3 | PER3* | Per3 | Alliance of Genome Resources | ||||
agammaglobulinemia 10 | SPI1* | Spi1 | Alliance of Genome Resources | ||||
agammaglobulinemia 5 | LRRC8A* | Lrrc8a | Alliance of Genome Resources | ||||
agammaglobulinemia 8A | TCF3* | Tcf3 | Alliance of Genome Resources | ||||
age related macular degeneration | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
age related macular degeneration | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | CFHR3* | Cfhr2 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | HMCN1* | Hmcn1 | Alliance of Genome Resources | ||||
age related macular degeneration 1 | APOE* | Apoe | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 1 | CFHR1*, CFHR2 | Cfhr1 | Alliance of Genome Resources | ||||
age related macular degeneration 11 | CST3* | Cst3 | Alliance of Genome Resources | ||||
age related macular degeneration 13 | CFI* | Cfi | Alliance of Genome Resources | ||||
age related macular degeneration 14 | CFB* | Cfb | Alliance of Genome Resources | ||||
age related macular degeneration 14 | C2* | C2 | Alliance of Genome Resources | ||||
age related macular degeneration 15 | C9* | C9 | Alliance of Genome Resources | ||||
age related macular degeneration 2 | ABCA4* | Abca4 | 1 model | Alliance of Genome Resources | |||
age related macular degeneration 5 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
age related macular degeneration 6 | RAX2* | ||||||
age related macular degeneration 7 | C3* | C3 | Alliance of Genome Resources | ||||
age related macular degeneration 7 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
age related macular degeneration 8 | ARMS2* | ||||||
age related macular degeneration 9 | C3* | C3 | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | MPO* | Mpo | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | PLAU* | Plau | Alliance of Genome Resources | ||||
Alzheimer's disease 1 | APP* | App | Alliance of Genome Resources | ||||
Alzheimer's disease 2 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 3 | APOE* | Apoe | Alliance of Genome Resources | ||||
Alzheimer's disease 4 | PSEN2* | Psen2 | 1 model | Alliance of Genome Resources | |||
Alzheimer's disease 9 | ABCA7* | Abca7 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 1A | LAMB3* | Lamb3 | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 3A | FAM83H* | Fam83h | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 3B | AMTN* | Amtn | Alliance of Genome Resources | ||||
amelogenesis imperfecta type 4 | DLX3* | Dlx3 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | NEFH* | Nefh | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 1 | PRPH* | Prph | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 24 | NEK1* | Nek1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 25 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 26 | TIA1* | Tia1 | Alliance of Genome Resources | ||||
amyotrophic lateral sclerosis type 28 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
Andersen-Tawil syndrome | KCNJ2* | Kcnj2 | Alliance of Genome Resources | ||||
aniridia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 1 | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
anterior segment dysgenesis 4 | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Antley-Bixler syndrome without disordered steroidogenesis | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
aortic valve disease 1 | NOTCH1* | Notch1 | Alliance of Genome Resources | ||||
aortic valve disease 2 | FTO* | Fto | Alliance of Genome Resources | ||||
aortic valve disease 2 | SMAD6* | Smad6 | Alliance of Genome Resources | ||||
aortic valve disease 2 | NKX2-5* | Nkx2-5 | Alliance of Genome Resources | ||||
aortic valve disease 3 | ROBO4* | Robo4 | Alliance of Genome Resources | ||||
aplasia of lacrimal and salivary glands | FGF10* | Fgf10 | Alliance of Genome Resources | ||||
apolipoprotein C-III deficiency | APOC3* | Apoc3 | Alliance of Genome Resources | ||||
APP-related cerebral amyloid angiopathy | APP* | App | Alliance of Genome Resources | ||||
Arboleda-Tham syndrome | KAT6A* | Kat6a | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 1 | TGFB3* | Tgfb3 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 13 | CTNNA3* | Ctnna3 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 14 | CDH2* | Cdh2 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 5 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
arrhythmogenic right ventricular dysplasia 9 | PKP2* | Pkp2 | Alliance of Genome Resources | ||||
atrial heart septal defect 5 | ACTC1* | Actc1 | Alliance of Genome Resources | ||||
atrial heart septal defect 6 | TLL1* | Tll1 | Alliance of Genome Resources | ||||
atrial heart septal defect 8 | CITED2* | Cited2 | Alliance of Genome Resources | ||||
atrial heart septal defect 9 | GATA6* | Gata6 | Alliance of Genome Resources | ||||
atrial standstill 1 | GJA5* | Gja5 | Alliance of Genome Resources | ||||
autoimmune lymphoproliferative syndrome type 2A | CASP10* | ||||||
autoimmune lymphoproliferative syndrome type 4 | NRAS* | Nras | Alliance of Genome Resources | ||||
autoimmune lymphoproliferative syndrome type 4 | KRAS* | Kras | Alliance of Genome Resources | ||||
autosomal dominant Alport syndrome | MYH9* | Myh9 | Alliance of Genome Resources | ||||
autosomal dominant Alport syndrome | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
autosomal dominant auditory neuropathy 3 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant beta thalassemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | FGF14* | Fgf14 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | NPTX1* | Nptx1 | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia | SAMD9L* | Samd9l | Alliance of Genome Resources | ||||
autosomal dominant cerebellar ataxia, deafness and narcolepsy | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
autosomal dominant craniodiaphyseal dysplasia | SOST* | Sost | Alliance of Genome Resources | ||||
autosomal dominant craniometaphyseal dysplasia | ANKH* | Ank | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 1 | ELN* | Eln | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 2 | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
autosomal dominant cutis laxa 3 | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 10 | EMILIN1* | Emilin1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 11 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 12 | REEP1* | Reep1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 13 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 14 | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 3 | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 4 | HSPB3* | Hspb3 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 5 | GARS1* | Gars1 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 6 | FBXO38* | Fbxo38 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 7 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 8 | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
autosomal dominant distal hereditary motor neuronopathy 9 | WARS1* | Wars1 | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 1 | TERC* | ||||||
autosomal dominant dyskeratosis congenita 2 | TERT* | Tert | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 3 | TINF2* | Tinf2 | Alliance of Genome Resources | ||||
autosomal dominant dyskeratosis congenita 6 | ACD* | Acd | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | SYNE2* | Syne2 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 7 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant hyaline body myopathy | MYH7* | Myh7 | Alliance of Genome Resources | ||||
autosomal dominant hypocalcemia | CASR* | Casr | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SRRM2* | Srrm2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TLK2* | Tlk2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TRIO* | Trio | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | ZNF292* | Zfp292 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SETD2* | Setd2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | SET*, SETSIP | Set | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | RFX7* | Rfx7 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | MED13* | Med13 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | LMAN2L* | Lman2l | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | KDM4B* | Kdm4b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | TAF4* | Taf4 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | HNRNPC* | Hnrnpc | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | GRIA1* | Gria1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | DLG4* | Dlg4 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | DIP2B* | Dip2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | CAMK2G* | Camk2g | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | ATP2B1* | Atp2b1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder | AP2M1* | Ap2m1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 1 | MBD5* | Mbd5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 10 | CACNG2* | Cacng2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 11 | EPB41L1* | Epb41l1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 13 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 19 | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 21 | CTCF* | Ctcf | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 22 | ZBTB18* | Zbtb18 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 23 | SETD5* | Setd5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 29 | SETBP1* | Setbp1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 3 | CDH15* | Cdh15 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 30 | ZMYND11* | Zmynd11 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 31 | PURA* | Pura | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 33 | DPP6* | Dpp6 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 34 | CERT1* | Cert1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 35 | PPP2R5D* | Ppp2r5d | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 36 | PPP2R1A* | Ppp2r1a | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 40 | CHAMP1* | Champ1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 41 | TBL1XR1* | Tbl1xr1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 42 | GNB1* | Gnb1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 43 | HIVEP2* | Hivep2 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 44 | TRIO* | Trio | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 45 | CIC* | Cic | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 46 | KCNQ5* | Kcnq5 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 47 | STAG1* | Stag1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 48 | RAC1* | Rac1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 5 | SYNGAP1* | Syngap1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 50 | NAA15* | Naa15 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 51 | KMT5B* | Kmt5b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 52 | ASH1L* | Ash1l | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 53 | CAMK2A* | Camk2a | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 54 | CAMK2B* | Camk2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 55 | NUS1* | Nus1 | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 56 | CLTC* | Cltc | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 6 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
autosomal dominant intellectual developmental disorder 8 | GRIN1* | Grin1 | Alliance of Genome Resources | ||||
autosomal dominant isolated ectopia lentis 1 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
autosomal dominant isolated macrothrombocytopenia 1 | TUBB1* | Tubb1 | Alliance of Genome Resources | ||||
autosomal dominant keratitis | PAX6* | Pax6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 1 | DNAJB6* | Dnajb6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 2 | TNPO3* | Tnpo3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 3 | HNRNPDL* | Hnrnpdl | Alliance of Genome Resources | ||||
autosomal dominant mutilating palmoplantar keratoderma with periorificial keratotic plaques | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy | CHRNB2* | Chrnb2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 1 | CHRNA4* | Chrna4 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nocturnal frontal lobe epilepsy 4 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
autosomal dominant nocturnal frontal lobe epilepsy 5 | KCNT1* | Kcnt1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP2B2* | Atp2b2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ELMOD3* | Elmod3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | EPHA10* | Epha10 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | GREB1L* | Greb1l | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MAP1B* | Map1b | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | MYO3A* | Myo3a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | ATOH1* | Atoh1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | PI4KB* | Pi4kb | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | THOC1* | Thoc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness | USP48* | Usp48 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 1 | DIAPH1* | Diaph1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 10 | EYA4* | Eya4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 11 | MYO7A* | Myo7a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 15 | POU4F3* | Pou4f3 | 1 "NOT" model | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 17 | MYH9* | Myh9 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 20 | ACTG1* | Actg1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 21 | RIPOR2* | Ripor2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 23 | SIX1* | Six1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 27 | REST* | Rest | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 28 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2A | KCNQ4* | Kcnq4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 2B | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 34 | NLRP3* | Nlrp3 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3A | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 3B | GJB6* | Gjb6 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 40 | CRYM* | Crym | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 44 | CCDC50* | Ccdc50 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4A | MYH14* | Myh14 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 4B | CEACAM16* | Ceacam16 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 5 | GSDME* | Gsdme | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 50 | MIR96* | Mir96 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 56 | TNC* | Tnc | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 6 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 64 | DIABLO* | Diablo | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 65 | TBC1D24* | Tbc1d24 | 2 "NOT" models | Alliance of Genome Resources | |||
autosomal dominant nonsyndromic deafness 66 | CD164* | Cd164 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 68 | HOMER2* | Homer2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 69 | KITLG* | Kitl | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 7 | LMX1A* | Lmx1a | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 70 | MCM2* | Mcm2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 71 | DMXL2* | Dmxl2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 72 | SLC44A4* | Slc44a4 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 73 | PTPRQ* | Ptprq | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 74 | PDE1C* | Pde1c | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 75 | TRRAP* | Trrap | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 76 | PLS1* | Pls1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 77 | ABCC1* | Abcc1 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 78 | SLC12A2* | Slc12a2 | Alliance of Genome Resources | ||||
autosomal dominant nonsyndromic deafness 79 | SCD5* | ||||||
autosomal dominant osteopetrosis 1 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | MTOR* | Mtor | Alliance of Genome Resources | ||||
autosomal dominant polycystic kidney disease | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia 1 | POLG* | Polg | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | TWNK* | Twnk | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | POLG2* | Polg2 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | RRM2B* | Rrm2b | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 6 | DNA2* | Dna2 | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 1 | WNT5A* | Wnt5a | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 2 | DVL1*, DVL1P1 | Dvl1 | Alliance of Genome Resources | ||||
autosomal dominant Robinow syndrome 3 | DVL3* | Dvl3 | Alliance of Genome Resources | ||||
autosomal dominant sensory ataxia 1 | RNF170* | Rnf170 | Alliance of Genome Resources | ||||
autosomal dominant sideroblastic anemia 4 | HSPA9* | Hspa9 | Alliance of Genome Resources | ||||
autosomal dominant thrombophilia due to protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
autosomal dominant thrombophilia due to protein S deficiency | PROS1* | Pros1 | Alliance of Genome Resources | ||||
autosomal dominant vitreoretinochoroidopathy | BEST1* | Best1 | Alliance of Genome Resources | ||||
autosomal dominant Wolfram syndrome | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
autosomal dominant woolly hair | KRT74* | Krt74 | Alliance of Genome Resources | ||||
autosomal recessive thrombophilia due to protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Axenfeld-Rieger syndrome type 3 | FOXC1* | Foxc1 | Alliance of Genome Resources | ||||
Ayme-Gripp syndrome | MAF* | Maf | Alliance of Genome Resources | ||||
Bainbridge-Ropers syndrome | ASXL3* | Asxl3 | Alliance of Genome Resources | ||||
Baraitser-Winter syndrome 1 | ACTB* | Actb | Alliance of Genome Resources | ||||
Baraitser-Winter syndrome 2 | ACTG1* | Actg1 | Alliance of Genome Resources | ||||
Bart-Pumphrey syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
benign familial hematuria | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
benign familial hematuria | COL4A4* | Col4a4 | Alliance of Genome Resources | ||||
benign familial infantile seizures 2 | PRRT2* | Prrt2 | Alliance of Genome Resources | ||||
benign familial infantile seizures 3 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
benign familial infantile seizures 5 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
benign familial infantile seizures 6 | CHRNA2* | Chrna2 | Alliance of Genome Resources | ||||
Beukes hip dysplasia | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
bilateral optic nerve hypoplasia | PAX6* | Pax6 | Alliance of Genome Resources | ||||
Birk-Barel syndrome | KCNK9* | Kcnk9 | Alliance of Genome Resources | ||||
Birt-Hogg-Dube syndrome | PRDM10* | Prdm10 | Alliance of Genome Resources | ||||
Blau syndrome | NOD2* | Nod2 | Alliance of Genome Resources | ||||
blepharocheilodontic syndrome 1 | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
blepharocheilodontic syndrome 2 | CTNND1* | Ctnnd1 | Alliance of Genome Resources | ||||
blepharophimosis-impaired intellectual development syndrome | SMARCA2* | Smarca2 | Alliance of Genome Resources | ||||
blue color blindness | OPN1SW* | Opn1sw | Alliance of Genome Resources | ||||
Bothnian type palmoplantar keratoderma | AQP5* | Aqp5 | Alliance of Genome Resources | ||||
brachycephaly, trichomegaly, and developmental delay | RPS23* | Rps23 | Alliance of Genome Resources | ||||
brachydactyly-syndactyly syndrome | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly type A1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
brachydactyly type A1D | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
brachydactyly type D | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brain small vessel disease 2 | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
branchiooculofacial syndrome | TFAP2A* | Tfap2a | Alliance of Genome Resources | ||||
branchiootorenal syndrome | PAX1* | Pax1 | Alliance of Genome Resources | ||||
branchiootorenal syndrome 1 | EYA1* | Eya1 | Alliance of Genome Resources | ||||
branchiootorenal syndrome 2 | SIX5* | Six5 | Alliance of Genome Resources | ||||
bronchiectasis 1 | SCNN1B* | Scnn1b | Alliance of Genome Resources | ||||
bronchiectasis 1 | CFTR* | Cftr | Alliance of Genome Resources | ||||
bronchiectasis 2 | SCNN1A* | Scnn1a | Alliance of Genome Resources | ||||
bronchiectasis 3 | SCNN1G* | Scnn1g | Alliance of Genome Resources | ||||
Brooke-Spiegler syndrome | CYLD* | Cyld | Alliance of Genome Resources | ||||
Brugada syndrome 9 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
Buschke-Ollendorff syndrome | LEMD3* | Lemd3 | Alliance of Genome Resources | ||||
CADASIL 2 | HTRA1* | Htra1 | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 1 | BRAF* | Braf | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 2 | KRAS* | Kras | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 3 | MAP2K1* | Map2k1 | Alliance of Genome Resources | ||||
cardiofaciocutaneous syndrome 4 | MAP2K2* | Map2k2 | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHD* | Sdhd | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHC* | Sdhc | Alliance of Genome Resources | ||||
Carney-Stratakis syndrome | SDHB* | Sdhb | Alliance of Genome Resources | ||||
carpal tunnel syndrome 1 | TTR* | Ttr | Alliance of Genome Resources | ||||
carpal tunnel syndrome 2 | COMP* | Comp | Alliance of Genome Resources | ||||
cataract 11 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
cataract 12 multiple types | BFSP2* | Bfsp2 | Alliance of Genome Resources | ||||
cataract 17 multiple types | CRYBB1* | Crybb1 | Alliance of Genome Resources | ||||
cataract 22 multiple types | CRYBB3* | Crybb3 | Alliance of Genome Resources | ||||
cataract 31 multiple types | CHMP4B* | Chmp4b | Alliance of Genome Resources | ||||
cataract 33 | BFSP1* | Bfsp1 | Alliance of Genome Resources | ||||
cataract 41 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
cataract 42 | CRYBA2* | Cryba2 | Alliance of Genome Resources | ||||
cataract 43 | UNC45B* | Unc45b | Alliance of Genome Resources | ||||
cataract 47 | SLC16A12* | Slc16a12 | Alliance of Genome Resources | ||||
cataract 7 | CRYGD* | Crygd, Cryge, Crygf | Alliance of Genome Resources | ||||
cataract 9 multiple types | PITX3* | Pitx3 | Alliance of Genome Resources | ||||
central conducting lymphatic anomaly | EPHB4* | Ephb4 | Alliance of Genome Resources | ||||
central precocious puberty 1 | KISS1R* | Kiss1r | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | MTMR14* | Mtmr14 | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
centronuclear myopathy 4 | CCDC78* | Ccdc78 | Alliance of Genome Resources | ||||
cerebellar ataxia type 41 | TRPC3* | Trpc3 | Alliance of Genome Resources | ||||
cerebellar ataxia type 43 | MME* | Mme | Alliance of Genome Resources | ||||
cerebellar ataxia type 47 | PUM1* | Pum1 | Alliance of Genome Resources | ||||
cerebellar ataxia type 48 | STUB1* | Stub1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2CC | NEFH* | Nefh | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2F | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2K | JPH1* | Jph1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2L | HSPB8* | Hspb8 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2N | AARS1* | Aars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2T | MME* | Mme | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2U | MARS1* | Mars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2V | NAGLU* | Naglu | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease, axonal type 2W | HARS1* | Hars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate A | GBF1* | Gbf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate B | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate D | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate E | INF2* | Inf2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate F | GNB4* | Gnb4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate G | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1D | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1F | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1G | PMP2* | Pmp2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2DD | ATP1A1* | Atp1a1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2I | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2J | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2Y | VCP* | Vcp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | EGR2* | Egr2 | Alliance of Genome Resources | ||||
childhood-onset neurodegeneration with brain atrophy | UBTF* | Ubtf | Alliance of Genome Resources | ||||
chromosome 15q24 deletion syndrome | SIN3A* | Sin3a | Alliance of Genome Resources | ||||
Clark-Baraitser syndrome | TRIP12* | Trip12 | Alliance of Genome Resources | ||||
cleft palate, cardiac defects, and intellectual disabillity | MEIS2* | Meis2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome | ARID1B* | Arid1b | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 10 | SOX4* | Sox4 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 11 | SMARCD1* | Smarcd1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 12 | BICRA* | Bicra | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 2 | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 3 | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 4 | SMARCA4* | Smarca4 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 5 | SMARCE1* | Smarce1 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 6 | ARID2* | Arid2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 7 | DPF2* | Dpf2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 8 | SMARCC2* | Smarcc2 | Alliance of Genome Resources | ||||
Coffin-Siris syndrome 9 | SOX11* | Sox11 | Alliance of Genome Resources | ||||
common variable immunodeficiency 10 | NFKB2* | Nfkb2 | Alliance of Genome Resources | ||||
common variable immunodeficiency 13 | IKZF1* | Ikzf1 | Alliance of Genome Resources | ||||
common variable immunodeficiency 14 | IRF2BP2* | Irf2bp2 | Alliance of Genome Resources | ||||
common variable immunodeficiency 2 | TNFRSF13B* | Tnfrsf13b | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CAMSAP1* | Camsap1 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | CTNNA2* | Ctnna2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | KIF26A* | Kif26a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations | APC2* | Apc2 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 1 | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 2 | KIF5C* | Kif5c | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 3 | KIF2A* | Kif2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 5 | TUBB2A* | Tubb2a | Alliance of Genome Resources | ||||
complex cortical dysplasia with other brain malformations 6 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
cone-rod dystrophy 24 | UNC119* | Unc119 | Alliance of Genome Resources | ||||
congenital adrenal insufficiency | CYP11A1* | Cyp11a1 | Alliance of Genome Resources | ||||
congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | SON* | Son | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | BDNF* | Bdnf | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | MYO1H* | Myo1h | Alliance of Genome Resources | ||||
congenital central hypoventilation syndrome | LBX1* | Lbx1 | Alliance of Genome Resources | ||||
congenital contractural arachnodactyly | FBN2* | Fbn2 | Alliance of Genome Resources | ||||
congenital diarrhea 6 | GUCY2C* | Gucy2c | Alliance of Genome Resources | ||||
congenital dyserythropoietic anemia type IV | KLF1* | Klf1 | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 1 | KIF21A* | Kif21a | Alliance of Genome Resources | ||||
congenital fibrosis of the extraocular muscles 3A | TUBB3* | Tubb3 | Alliance of Genome Resources | ||||
congenital limbs-face contractures-hypotonia-developmental delay syndrome | NALCN* | Nalcn | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 18 | SNAP25* | Snap25 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CAST* | Cast | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1B | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2A | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 7 | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital myopathy 15 | TNNC2* | Tnnc2 | Alliance of Genome Resources | ||||
congenital myopathy 16 | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
congenital myopathy 18 | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
congenital myopathy 2C | ACTA1* | Acta1 | Alliance of Genome Resources | ||||
congenital myopathy 4A | TPM3* | Tpm3 | Alliance of Genome Resources | ||||
congenital myopathy 6 | MYH2* | Myh2 | Alliance of Genome Resources | ||||
congenital myopathy 8 | ACTN2* | Actn2 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 2 | PAX8* | Pax8 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 5 | NKX2-5* | Nkx2-5 | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 6 | THRA* | Thra | Alliance of Genome Resources | ||||
congenital nongoitrous hypothyroidism 8 | TBL1X*, TBL1Y | Tbl1x | Alliance of Genome Resources | ||||
congenital stationary night blindness autosomal dominant 3 | GNAT1* | Gnat1 | Alliance of Genome Resources | ||||
congenital symmetric circumferential skin creases 1 | TUBB* | Tubb5 | Alliance of Genome Resources | ||||
congenital symmetric circumferential skin creases 2 | MAPRE2* | Mapre2 | Alliance of Genome Resources | ||||
congenital vertical talus | HOXD10* | Hoxd10 | Alliance of Genome Resources | ||||
contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A | MYH3* | Myh3 | Alliance of Genome Resources | ||||
Cornelia de Lange syndrome 4 | RAD21* | Rad21 | Alliance of Genome Resources | ||||
Cornelia de Lange syndrome 6 | BRD4* | Brd4 | Alliance of Genome Resources | ||||
craniofacial-deafness-hand syndrome | PAX3* | Pax3 | Alliance of Genome Resources | ||||
Crouzon syndrome-acanthosis nigricans syndrome | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
CST3-related cerebral amyloid angiopathy | CST3* | Cst3 | Alliance of Genome Resources | ||||
C syndrome | CD96* | Cd96 | Alliance of Genome Resources | ||||
Culler-Jones syndrome | GLI2* | Gli2 | Alliance of Genome Resources | ||||
Currarino syndrome | MNX1* | Mnx1 | Alliance of Genome Resources | ||||
D-2-hydroxyglutaric aciduria 2 | IDH2* | Idh2 | Alliance of Genome Resources | ||||
dehydrated hereditary stomatocytosis 1 | PIEZO1* | Piezo1 | Alliance of Genome Resources | ||||
dehydrated hereditary stomatocytosis 2 | KCNN4* | Kcnn4 | Alliance of Genome Resources | ||||
delta beta-thalassemia | HBG1*, HBG2*, HBE1 | Hbb-bh0, Hbb-bh1, Hbb-y | Alliance of Genome Resources | ||||
delta beta-thalassemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
dentatorubral-pallidoluysian atrophy | ATN1* | Atn1 | Alliance of Genome Resources | ||||
dentinogenesis imperfecta | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
dermatopathia pigmentosa reticularis | KRT14* | Krt14 | Alliance of Genome Resources | ||||
DeSanto-Shinawi syndrome | WAC* | Wac | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 100 | FBXO28* | Fbxo28 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 103 | KCNC2* | Kcnc2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 104 | ATP6V0A1* | Atp6v0a1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 108 | MAST3* | Mast3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 109 | FZR1* | Fzr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 11 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 116 | GLUL* | Glul | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 13 | SCN8A* | Scn8a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 19 | GABRA1* | Gabra1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 24 | HCN1* | Hcn1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 26 | KCNB1* | Kcnb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 27 | GRIN2B* | Grin2b | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 30 | SIK1* | Sik1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 31A | DNM1* | Dnm1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 32 | KCNA2* | Kcna2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 33 | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 4 | STXBP1* | Stxbp1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 41 | SLC1A2* | Slc1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 42 | CACNA1A* | Cacna1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 43 | GABRB3* | Gabrb3 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 45 | GABRB1* | Gabrb1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 46 | GRIN2D* | Grin2d | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 47 | FGF12* | Fgf12 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 5 | SPTAN1* | Sptan1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 56 | YWHAG* | Ywhag | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 57 | KCNT2* | Kcnt2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 58 | NTRK2* | Ntrk2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 59 | GABBR2* | Gabbr2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 62 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 64 | RHOBTB2* | Rhobtb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 65 | CYFIP2* | Cyfip2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 66 | PACS2* | Pacs2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 67 | CUX2* | Cux2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 69 | CACNA1E* | Cacna1e | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 6B | SCN1A* | Scn1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 70 | PHACTR1* | Phactr1 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 72 | NEUROD2* | Neurod2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 73 | RNF13* | Rnf13 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 74 | GABRG2* | Gabrg2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 78 | GABRA2* | Gabra2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 79 | GABRA5* | Gabra5 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 87 | CDK19* | Cdk19 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 91 | PPP3CA* | Ppp3ca | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 92 | GABRB2* | Gabrb2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 93 | ATP6V1A* | Atp6v1a | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 96 | NSF* | Nsf | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 97 | CELF2* | Celf2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 98 | ATP1A2* | Atp1a2 | Alliance of Genome Resources | ||||
developmental and epileptic encephalopathy 99 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
developmental delay, dysmorphic facies, and brain anomalies | U2AF2* | U2af2 | Alliance of Genome Resources | ||||
developmental delay, hypotonia, and impaired language | FBXW7* | Fbxw7 | Alliance of Genome Resources | ||||
developmental dysplasia of the hip 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 1 | RPS19* | Rps19 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 10 | RPS26* | Rps26 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 11 | RPL26* | Rpl26 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 12 | RPL15* | Rpl15 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 13 | RPS29* | Rps29 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 15 with mandibulofacial dysostosis | RPS28* | Rps28 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 16 | RPL27* | Rpl27 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 17 | RPS27* | Rps27, Rps27rt | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 18 | RPL18* | Rpl18 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 19 | RPL35* | Rpl35, Rpl35rt | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 20 | RPS15A* | Rps15a | Alliance of Genome Resources | ||||
Diamond-blackfan anemia 3 | RPS24* | Rps24 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 4 | RPS17* | Rps17 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 5 | RPL35A* | Rpl35a | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 8 | RPS7* | Rps7 | Alliance of Genome Resources | ||||
Diamond-Blackfan anemia 9 | RPS10* | Rps10 | Alliance of Genome Resources | ||||
diaphyseal medullary stenosis with malignant fibrous histiocytoma | MTAP* | Mtap | Alliance of Genome Resources | ||||
DICER1 syndrome | DICER1* | Dicer1 | Alliance of Genome Resources | ||||
diffuse cystic renal dysplasia | BICC1* | Bicc1 | Alliance of Genome Resources | ||||
DiGeorge syndrome | ARVCF* | Arvcf | 2 models | Alliance of Genome Resources | |||
DiGeorge syndrome | DVL1*, DVL1P1* | Dvl1 | Alliance of Genome Resources | ||||
DiGeorge syndrome | UFD1* | Ufd1 | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1AA | ACTN2* | Actn2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1B | FKTN* | Fktn | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1E | SCN5A* | Scn5a | 2 models | Alliance of Genome Resources | |||
dilated cardiomyopathy 1II | CRYAB* | Cryab | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1JJ | LAMA4* | Lama4 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1KK | MYPN* | Mypn | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1LL | PRDM16* | Prdm16 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1MM | MYBPC3* | Mybpc3 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1NN | RAF1* | Raf1 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1S | MYH7* | Myh7 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1U | PSEN1* | Psen1 | Alliance of Genome Resources | ||||
dilated cardiomyopathy 1V | PSEN2* | Psen2 | Alliance of Genome Resources | ||||
dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome | LMNA* | Lmna | Alliance of Genome Resources | ||||
distal arthrogryposis type 1A | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1B | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2A | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B1 | TNNI2* | Tnni2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B2 | TNNT3* | Tnnt3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B3 | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 3 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 5 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 7 | MYH8* | Myh8 | Alliance of Genome Resources | ||||
distal myopathy 1 | MYH7* | Myh7 | Alliance of Genome Resources | ||||
distal myopathy 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
distal myopathy Tateyama type | CAV3* | Cav3 | Alliance of Genome Resources | ||||
distal myopathy with rimmed vacuoles | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
dominant optic atrophy plus syndrome | OPA1* | Opa1 | Alliance of Genome Resources | ||||
dopa-responsive dystonia | GCH1* | Gch1 | Alliance of Genome Resources | ||||
dysplastic nevus syndrome | CDKN2A* | Cdkn2a | 1 "NOT" model | Alliance of Genome Resources | |||
dystonia 12 | PLA2G6* | Pla2g6 | Alliance of Genome Resources | ||||
dystonia 12 | ATP1A3* | Atp1a3 | Alliance of Genome Resources | ||||
dystonia 24 | ANO3* | Ano3 | Alliance of Genome Resources | ||||
dystonia 25 | GNAL* | Gnal | Alliance of Genome Resources | ||||
dystonia 28, childhood-onset | KMT2B* | Kmt2b | Alliance of Genome Resources | ||||
dystonia 30 | VPS16* | Vps16 | Alliance of Genome Resources | ||||
dystonia 33 | EIF2AK2* | Eif2ak2 | Alliance of Genome Resources | ||||
dystonia 9 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
dystransthyretinemic hyperthyroxinemia | TTR* | Ttr | Alliance of Genome Resources | ||||
early-onset dystonia and/or spastic paraplegia | ATP5MC3* | Atp5mc3 | Alliance of Genome Resources | ||||
early-onset epilepsy 2 | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
early-onset epilepsy 3 | ATP6V0C* | Atp6v0c | Alliance of Genome Resources | ||||
ectodermal dysplasia 10A | EDAR* | Edar | Alliance of Genome Resources | ||||
ectodermal dysplasia 11A | EDARADD* | Edaradd | Alliance of Genome Resources | ||||
ectodermal dysplasia 12 | KDF1* | Kdf1 | Alliance of Genome Resources | ||||
ectodermal dysplasia and immunodeficiency 2 | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
EEC syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 1 | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome classic type 2 | COL5A2* | Col5a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 1 | C1R* | C1ra, C1rb | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 2 | C1S* | C1s1, C1s2 | Alliance of Genome Resources | ||||
epidermolysis bullosa simplex with mottled pigmentation | KRT5* | Krt5 | Alliance of Genome Resources | ||||
epidermolysis bullosa with congenital localized absence of skin and deformity of nails | COL7A1* | Col7a1 | Alliance of Genome Resources | ||||
epidermolytic hyperkeratosis 1 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
epidermolytic palmoplantar keratoderma 1 | KRT9* | Krt9 | Alliance of Genome Resources | ||||
epidermolytic palmoplantar keratoderma 2 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
episodic ataxia type 9 | SCN2A* | Scn2a | Alliance of Genome Resources | ||||
episodic kinesigenic dyskinesia 3 | TMEM151A* | Tmem151a | Alliance of Genome Resources | ||||
epithelial basement membrane dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
epithelial recurrent erosion dystrophy | COL17A1* | Col17a1 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 1 | GJB3* | Gjb3 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 2 | GJB4* | Gjb4 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 3 | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
erythrokeratodermia variabilis et progressiva 6 | TRPM4* | Trpm4 | Alliance of Genome Resources | ||||
essential tremor 1 | DRD3* | Drd3 | Alliance of Genome Resources | ||||
essential tremor 4 | FUS* | Fus | Alliance of Genome Resources | ||||
essential tremor 5 | TENM4* | Tenm4 | Alliance of Genome Resources | ||||
essential tremor 6 | NOTCH2NLC* | ||||||
exudative vitreoretinopathy 1 | FZD4* | Fzd4 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 5 | TSPAN12* | Tspan12 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 6 | ZNF408* | Zfp408 | Alliance of Genome Resources | ||||
exudative vitreoretinopathy 7 | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
familial adenomatous polyposis 1 | APC* | Apc | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 1 | SAMD12* | Samd12 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 2 | STARD7* | Stard7 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 3 | MARCHF6* | Marchf6 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 4 | YEATS2* | Yeats2 | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 6 | TNRC6A* | Tnrc6a | Alliance of Genome Resources | ||||
familial adult myoclonic epilepsy 7 | RAPGEF2* | Rapgef2 | Alliance of Genome Resources | ||||
familial apolipoprotein A5 deficiency | APOA5* | Apoa5 | Alliance of Genome Resources | ||||
familial Behcet-like autoinflammatory syndrome | TNFAIP3* | Tnfaip3 | Alliance of Genome Resources | ||||
familial cold autoinflammatory syndrome 2 | NLRP12* | Nlrp12 | Alliance of Genome Resources | ||||
familial cold autoinflammatory syndrome 3 | PLCG2* | Plcg2 | Alliance of Genome Resources | ||||
familial encephalopathy with neuroserpin inclusion bodies | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 1 | TRPA1* | Trpa1 | Alliance of Genome Resources | ||||
familial episodic pain syndrome 2 | SCN10A* | Scn10a | Alliance of Genome Resources | ||||
familial erythrocytosis 1 | SH2B3* | Sh2b3 | Alliance of Genome Resources | ||||
familial erythrocytosis 1 | JAK2* | Jak2 | Alliance of Genome Resources | ||||
familial erythrocytosis 1 | EPOR* | Epor | 2 models | Alliance of Genome Resources | |||
familial erythrocytosis 3 | EGLN1* | Egln1 | Alliance of Genome Resources | ||||
familial erythrocytosis 5 | EPO* | Epo | Alliance of Genome Resources | ||||
familial expansile osteolysis | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 1 | DEPDC5* | Depdc5 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 2 | NPRL2* | Nprl2 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 3 | NPRL3* | Nprl3 | Alliance of Genome Resources | ||||
familial focal epilepsy with variable foci 4 | SCN3A* | Scn3a | Alliance of Genome Resources | ||||
familial gestational hyperthyroidism | TSHR* | Tshr | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 1 | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 2 | KCNJ11* | Kcnj11 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 5 | INSR* | Insr | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 6 | GLUD1*, GLUD2 | Glud1 | Alliance of Genome Resources | ||||
familial hyperinsulinemic hypoglycemia 7 | SLC16A1* | Slc16a1 | Alliance of Genome Resources | ||||
familial hypocalciuric hypercalcemia 2 | GNA11* | Gna11 | Alliance of Genome Resources | ||||
familial hypocalciuric hypercalcemia 3 | AP2S1* | Ap2s1 | Alliance of Genome Resources | ||||
familial male-limited precocious puberty | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
familial medullary thyroid carcinoma | RET* | Ret | 2 "NOT" models | Alliance of Genome Resources | |||
familial partial lipodystrophy type 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 3 | PPARG* | Pparg | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 4 | PLIN1* | Plin1 | Alliance of Genome Resources | ||||
familial progressive hyperpigmentation with or without hypopigmentation | KITLG* | Kitl | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 5 | CPA6* | Cpa6 | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 7 | RELN* | Reln | Alliance of Genome Resources | ||||
familial temporal lobe epilepsy 8 | GAL* | Gal | Alliance of Genome Resources | ||||
familial visceral amyloidosis | FGA* | Fga | Alliance of Genome Resources | ||||
Fanconi anemia complementation group R | RAD51* | Rad51 | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 1 | GATM* | Gatm | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 3 | EHHADH* | Ehhadh | Alliance of Genome Resources | ||||
Fanconi renotubular syndrome 4 | HNF4A* | Hnf4a | Alliance of Genome Resources | ||||
Feingold syndrome | MYCN* | Mycn, Mycs | Alliance of Genome Resources | ||||
fibrochondrogenesis 2 | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
Finnish type amyloidosis | GSN* | Gsn | Alliance of Genome Resources | ||||
Floating-Harbor syndrome | SRCAP* | Srcap | Alliance of Genome Resources | ||||
focal nonepidermolytic palmoplantar keratoderma 1 | KRT16* | Krt16 | Alliance of Genome Resources | ||||
focal nonepidermolytic palmoplantar keratoderma 2 | TRPV3* | Trpv3 | Alliance of Genome Resources | ||||
focal or diffuse nonepidermolytic palmoplantar keratoderma | KRT6C*, KRT6A, KRT6B | Gm5414, Gm5478, Krt6a, Krt6b | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 5 | INF2* | Inf2 | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 7 | PAX2* | Pax2 | Alliance of Genome Resources | ||||
focal segmental glomerulosclerosis 8 | ANLN* | Anln | Alliance of Genome Resources | ||||
foveal hypoplasia 1 | PAX6* | Pax6 | Alliance of Genome Resources | ||||
Frasier syndrome | WT1* | Wt1 | Alliance of Genome Resources | ||||
frontometaphyseal dysplasia 2 | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
geleophysic dysplasia 2 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
geleophysic dysplasia 3 | LTBP3* | Ltbp3 | Alliance of Genome Resources | ||||
giant axonal neuropathy 2 | DCAF8* | Dcaf8 | Alliance of Genome Resources | ||||
gingival fibromatosis 5 | REST* | Rest | Alliance of Genome Resources | ||||
glomangioma | GLMN* | Glmn | Alliance of Genome Resources | ||||
glucose transporter type 1 deficiency syndrome 2 | SLC2A1* | Slc2a1 | Alliance of Genome Resources | ||||
granular corneal dystrophy 1 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
granular corneal dystrophy 2 | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
growth hormone insensitivity syndrome with immune dysregulation 2 | STAT5B* | Stat5b | Alliance of Genome Resources | ||||
Guttmacher syndrome | HOXA13* | Hoxa13 | Alliance of Genome Resources | ||||
Hailey-Hailey disease | ATP2C1* | Atp2c1 | 1 "NOT" model | Alliance of Genome Resources | |||
Harel-Yoon syndrome | ATAD3A*, ATAD3B, ATAD3C | Atad3a | Alliance of Genome Resources | ||||
hawkinsinuria | HPD* | Hpd | Alliance of Genome Resources | ||||
Heinz body anemia | HBB*, HBD | Hbb-b1, Hbb-b2, Hbb-bh2, Hbb-bs, Hbb-bt | Alliance of Genome Resources | ||||
Heinz body anemia | HBA1*, HBA2* | Hba-a1, Hba-a2 | Alliance of Genome Resources | ||||
Helsmoortel-Van Der Aa Syndrome | ADNP* | Adnp | Alliance of Genome Resources | ||||
heparin cofactor II deficiency | SERPIND1* | Serpind1 | Alliance of Genome Resources | ||||
hereditary angioedema | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
hereditary angioedema | ANGPT1* | Angpt1 | Alliance of Genome Resources | ||||
hereditary angioedema | MYOF* | Myof | Alliance of Genome Resources | ||||
hereditary angioedema | F12* | F12 | Alliance of Genome Resources | ||||
hereditary angioedema | PLG* | Plg | Alliance of Genome Resources | ||||
hereditary angioedema | KNG1* | Kng1, Kng2 | Alliance of Genome Resources | ||||
hereditary angioedema | HS3ST6* | Hs3st6 | Alliance of Genome Resources | ||||
hereditary angioedema type I | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
hereditary angioedema type III | F12* | F12 | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | RAD51D* | Rad51d | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | RAD51C* | Rad51c | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | PALB2* | Palb2 | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
hereditary breast ovarian cancer syndrome | BRCA1* | Brca1 | 3 models | Alliance of Genome Resources | |||
hereditary diffuse gastric cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
hereditary hemorrhagic telangiectasia | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
hereditary hemorrhagic telangiectasia | GDF2* | Gdf2 | Alliance of Genome Resources | ||||
hereditary lymphedema IA | FLT4* | Flt4 | Alliance of Genome Resources | ||||
hereditary lymphedema IC | GJC2* | Gjc2 | Alliance of Genome Resources | ||||
hereditary lymphedema ID | VEGFC* | Vegfc | Alliance of Genome Resources | ||||
hereditary mixed polyposis syndrome 2 | BMPR1A* | Bmpr1a | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 2 | MLH1* | Mlh1 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 4 | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 5 | MSH6* | Msh6 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 6 | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 7 | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
hereditary nonpolyposis colorectal cancer type 8 | EPCAM* | Epcam | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1A | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 1C | SPTLC2* | Sptlc2 | Alliance of Genome Resources | ||||
hereditary sensory and autonomic neuropathy type 7 | SCN11A* | Scn11a | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1D | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1E | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
hereditary sensory neuropathy type 1F | ATL3* | Atl3 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 10 | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 12 | RTN2* | Rtn2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 17 | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 3A | ATL1* | Atl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 42 | SLC33A1* | Slc33a1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 6 | NIPA1* | Nipa1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 72A | REEP2* | Reep2 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 73 | CPT1C* | Cpt1c | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 79A | UCHL1* | Uchl1 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 8 | WASHC5* | Washc5 | 1 "NOT" model | Alliance of Genome Resources | |||
hereditary spastic paraplegia 88 | KPNA3* | Kpna3 | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90A | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 90B | SPTSSA* | Sptssa | Alliance of Genome Resources | ||||
hereditary spastic paraplegia 9A | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
hereditary spherocytosis type 2 | SPTB* | Sptb | Alliance of Genome Resources | ||||
holoprosencephaly 12 | CNOT1* | Cnot1 | Alliance of Genome Resources | ||||
holoprosencephaly 4 | TGIF1* | Tgif1 | 1 "NOT" model | Alliance of Genome Resources | |||
holoprosencephaly 7 | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
holoprosencephaly 9 | GLI2* | Gli2 | Alliance of Genome Resources | ||||
Holt-Oram syndrome | SALL4* | Sall4 | Alliance of Genome Resources | ||||
hyperalphalipoproteinemia 1 | CETP* | ||||||
hyperferritinemia-cataract syndrome | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
hypertension and brachydactyly syndrome | PDE3A* | Pde3a | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 14 with or without anosmia | WDR11* | Wdr11 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 15 with or without anosmia | HS6ST1* | Hs6st1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 16 with or without anosmia | SEMA3A* | Sema3a | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 17 with or without anosmia | SPRY4* | Spry4 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 18 with or without anosmia | IL17RD* | Il17rd | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 19 with or without anosmia | DUSP6* | Dusp6 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 20 with or without anosmia | FGF17* | Fgf17 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 21 with or without anosmia | FLRT3* | Flrt3 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 2 with or without anosmia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 3 with or without anosmia | PROKR2* | Prokr2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 4 with or without anosmia | PROK2* | Prok2 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 5 with or without anosmia | CHD7* | Chd7 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 6 with or without anosmia | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
hypogonadotropic hypogonadism 9 with or without anosmia | NSMF* | Nsmf | Alliance of Genome Resources | ||||
hypoinsulinemic hypoglycemia with hemihypertrophy | AKT2* | Akt2 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 16 | TMEM106B* | Tmem106b | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 19 | TMEM63A* | Tmem63a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 22 | CLDN11* | Cldn11 | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 24 | ATP11A* | Atp11a | Alliance of Genome Resources | ||||
hypomyelinating leukodystrophy 25 | TMEM163* | Tmem163 | Alliance of Genome Resources | ||||
hypophosphatemic nephrolithiasis/osteoporosis 1 | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
hypophosphatemic nephrolithiasis/osteoporosis 2 | NHERF1* | Nherf1 | Alliance of Genome Resources | ||||
hypoplastic or aplastic tibia with polydactyly | SHH* | Shh | Alliance of Genome Resources | ||||
hypotonia, ataxia, and delayed development syndrome | EBF3* | Ebf3 | Alliance of Genome Resources | ||||
hypotrichosis 1 | SNRPE* | Snrpe, Snrpert | Alliance of Genome Resources | ||||
hypotrichosis 1 | APCDD1* | Apcdd1 | Alliance of Genome Resources | ||||
hypotrichosis 11 | SNRPE* | Snrpe, Snrpert | Alliance of Genome Resources | ||||
hypotrichosis 12 | RPL21* | Rpl21 | Alliance of Genome Resources | ||||
hypotrichosis 2 | CDSN* | Cdsn | Alliance of Genome Resources | ||||
hypotrichosis 3 | KRT74* | Krt74 | Alliance of Genome Resources | ||||
hypotrichosis 4 | HRURF* | ||||||
hypotrichosis 5 | EPS8L3* | Eps8l3 | Alliance of Genome Resources | ||||
hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | SOX18* | Sox18 | Alliance of Genome Resources | ||||
ichthyosis vulgaris | FLG* | ||||||
idiopathic pulmonary fibrosis | TERT* | Tert | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SETD2* | Setd2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | EHMT2* | Ehmt2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | CXCL5*, CXCL6 | Cxcl5 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | BRD4* | Brd4 | Alliance of Genome Resources | ||||
immunodeficiency 11B | CARD11* | Card11 | Alliance of Genome Resources | ||||
immunodeficiency 13 | UNC119* | Unc119 | Alliance of Genome Resources | ||||
immunodeficiency 14 | PIK3CD* | Pik3cd | Alliance of Genome Resources | ||||
immunodeficiency 21 | GATA2* | Gata2 | Alliance of Genome Resources | ||||
immunodeficiency 27B | IFNGR1* | Ifngr1 | Alliance of Genome Resources | ||||
immunodeficiency 31A | STAT1* | Stat1 | Alliance of Genome Resources | ||||
immunodeficiency 31C | STAT1* | Stat1 | Alliance of Genome Resources | ||||
immunodeficiency 32A | IRF8* | Irf8 | Alliance of Genome Resources | ||||
immunodeficiency 36 | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
immunodeficiency 39 | IRF7* | Irf7 | Alliance of Genome Resources | ||||
immunodeficiency 49 | BCL11B* | Bcl11b | Alliance of Genome Resources | ||||
immunodeficiency 60 | BACH2* | Bach2 | Alliance of Genome Resources | ||||
immunodeficiency 70 | IVNS1ABP* | Ivns1abp | Alliance of Genome Resources | ||||
immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis | RAC2* | Rac2 | Alliance of Genome Resources | ||||
inclusion body myopathy and brain white matter abnormalities | ANXA11* | Anxa11 | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1 | VCP* | Vcp | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 2 | HNRNPA2B1* | Hnrnpa2b1 | Alliance of Genome Resources | ||||
inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
inflammatory bowel disease 29 | INAVA* | Inava | Alliance of Genome Resources | ||||
inflammatory bowel disease 30 | CARD8* | ||||||
intellectual developmental disorder with autistic features and language delay, with or without seizures | TANC2* | Tanc2 | Alliance of Genome Resources | ||||
intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | TNPO2* | Tnpo2 | Alliance of Genome Resources | ||||
intellectual disability-severe speech delay-mild dysmorphism syndrome | FOXP1* | Foxp1 | Alliance of Genome Resources | ||||
interstitial lung disease 1 | SFTPA1*, SFTPA2 | Sftpa1 | Alliance of Genome Resources | ||||
interstitial lung disease 2 | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
interstitial lung disease 2 | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
intrahepatic cholestasis of pregnancy 1 | ATP8B1* | Atp8b1 | Alliance of Genome Resources | ||||
intrahepatic cholestasis of pregnancy 3 | ABCB4* | Abcb4 | Alliance of Genome Resources | ||||
ischiocoxopodopatellar syndrome | TBX4* | Tbx4 | Alliance of Genome Resources | ||||
isolated elevated serum creatine phosphokinase levels | ANO5* | Ano5 | Alliance of Genome Resources | ||||
isolated elevated serum creatine phosphokinase levels | CAV3* | Cav3 | Alliance of Genome Resources | ||||
isolated microphthalmia 7 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
ITM2B-related cerebral amyloid angiopathy 1 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
ITM2B-related cerebral amyloid angiopathy 2 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
IVIC syndrome | SALL4* | Sall4 | Alliance of Genome Resources | ||||
Jansen's metaphyseal chondrodysplasia | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
juvenile amyotrophic lateral sclerosis type 27 | SPTLC1* | Sptlc1 | Alliance of Genome Resources | ||||
juvenile glaucoma | MYOC* | Myoc | Alliance of Genome Resources | ||||
juvenile polyposis-hereditary hemorrhagic telangiectasia syndrome | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
Kenny-Caffey syndrome type 2 | FAM111A* | Fam111a | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 1 | DSG1* | Dsg1a, Dsg1b, Dsg1c | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 2 | DSP* | Dsp | Alliance of Genome Resources | ||||
keratosis palmoplantaris striata 3 | KRT1* | Krt1 | Alliance of Genome Resources | ||||
King Denborough syndrome | RYR1* | Ryr1 | Alliance of Genome Resources | ||||
Kleefstra syndrome 2 | KMT2C* | Kmt2c | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 1 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 3 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
Kniest dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 1 | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 2 | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
lacrimoauriculodentodigital syndrome 3 | FGF10* | Fgf10 | Alliance of Genome Resources | ||||
Larsen syndrome | FLNB* | Flnb | Alliance of Genome Resources | ||||
lateral meningocele syndrome | NOTCH3* | Notch3 | Alliance of Genome Resources | ||||
Laurin-Sandrow syndrome | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 11 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
Leber congenital amaurosis 13 | RDH12* | Rdh12 | Alliance of Genome Resources | ||||
Leber congenital amaurosis with early-onset deafness | TUBB4B* | Tubb4b | Alliance of Genome Resources | ||||
Legius syndrome | SPRED1* | Spred1 | Alliance of Genome Resources | ||||
Lenz-Majewski hyperostotic dwarfism | PTDSS1* | Ptdss1 | Alliance of Genome Resources | ||||
leucine-sensitive hypoglycemia of infancy | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
Li-Fraumeni syndrome 1 | TP53* | Trp53 | Alliance of Genome Resources | ||||
Li-Fraumeni syndrome 2 | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
lissencephaly 1 | PAFAH1B1* | Pafah1b1 | Alliance of Genome Resources | ||||
lissencephaly 10 | CEP85L* | Cep85l | Alliance of Genome Resources | ||||
lissencephaly 3 | TUBA1A* | Tuba1a | Alliance of Genome Resources | ||||
lissencephaly 9 with complex brainstem malformation | MACF1* | Macf1 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 1 | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 2 | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 3 | SMAD3* | Smad3 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 4 | TGFB2* | Tgfb2 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 5 | TGFB3* | Tgfb3 | Alliance of Genome Resources | ||||
Loeys-Dietz syndrome 6 | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
long QT syndrome 10 | SCN4B* | Scn4b | Alliance of Genome Resources | ||||
long QT syndrome 11 | AKAP9* | Akap9 | Alliance of Genome Resources | ||||
long QT syndrome 12 | SNTA1* | Snta1 | Alliance of Genome Resources | ||||
long QT syndrome 13 | KCNJ5* | Kcnj5 | Alliance of Genome Resources | ||||
long QT syndrome 14 | CALM1* | Calm1 | Alliance of Genome Resources | ||||
long QT syndrome 15 | CALM2* | Calm2 | Alliance of Genome Resources | ||||
long QT syndrome 16 | CALM3* | Calm3 | Alliance of Genome Resources | ||||
long QT syndrome 2 | ALG10B*, ALG10 | Alg10b | Alliance of Genome Resources | ||||
long QT syndrome 2 | KCNH2* | Kcnh2 | Alliance of Genome Resources | ||||
long QT syndrome 5 | KCNE1* | Kcne1 | Alliance of Genome Resources | ||||
long QT syndrome 6 | KCNE2* | Kcne2 | Alliance of Genome Resources | ||||
long QT syndrome 8 | CACNA1C* | Cacna1c | Alliance of Genome Resources | ||||
long QT syndrome 9 | CAV3* | Cav3 | Alliance of Genome Resources | ||||
Luo-Schoch-Yamamoto syndrome | RNF2* | Rnf2 | Alliance of Genome Resources | ||||
lymphedema-distichiasis syndrome | FOXC2* | Foxc2 | Alliance of Genome Resources | ||||
Lynch syndrome | ACVR2A* | Acvr2a | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD3* | Smad3 | Alliance of Genome Resources | ||||
Lynch syndrome | SLC22A9*, SLC22A10, SLC22A24, SLC22A25 | Slc22a19, Slc22a26, Slc22a27, Slc22a28, Slc22a29, Slc22a30 | Alliance of Genome Resources | ||||
Lynch syndrome | MRE11* | Mre11a | Alliance of Genome Resources | ||||
Lynch syndrome | MSH6* | Msh6 | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
Lynch syndrome | PMS1* | Pms1 | Alliance of Genome Resources | ||||
Lynch syndrome | TCF4* | Tcf4 | Alliance of Genome Resources | ||||
Lynch syndrome | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
Lynch syndrome | RNASET2* | Rnaset2a, Rnaset2b | Alliance of Genome Resources | ||||
Lynch syndrome | TAF1B* | Taf1b | Alliance of Genome Resources | ||||
Lynch syndrome | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
Lynch syndrome | RNASEL* | Rnasel | Alliance of Genome Resources | ||||
Lynch syndrome | MARCKS* | Marcks | Alliance of Genome Resources | ||||
Lynch syndrome | KRAS* | Kras | Alliance of Genome Resources | ||||
Lynch syndrome | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
Lynch syndrome | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
Lynch syndrome | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
Lynch syndrome | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
Lynch syndrome | E2F4* | E2f4 | Alliance of Genome Resources | ||||
Lynch syndrome | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
Lynch syndrome | ASTE1* | Aste1 | Alliance of Genome Resources | ||||
Lynch syndrome 1 | MSH2* | Msh2 | Alliance of Genome Resources | ||||
Machado-Joseph disease | BECN1* | Becn1 | Alliance of Genome Resources | ||||
Machado-Joseph disease | ATXN3* | Atxn3 | 1 model | Alliance of Genome Resources | |||
malignant hyperthermia | CACNG1* | Cacng1 | Alliance of Genome Resources | ||||
malignant hyperthermia | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
mandibulofacial dysostosis, Guion-Almeida type | EFTUD2* | Eftud2 | 2 "NOT" models | Alliance of Genome Resources | |||
maturity-onset diabetes of the young | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 10 | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 11 | BLK* | Blk | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 13 | KCNJ11* | Kcnj11 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 14 | APPL1* | Appl1 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 5 | HNF1B* | Hnf1b | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 6 | NEUROD1* | Neurod1 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 7 | KLF11* | Klf11 | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 8 | CEL* | Cel | Alliance of Genome Resources | ||||
maturity-onset diabetes of the young type 9 | PAX4* | Pax4 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 1 | KRT12* | Krt12 | Alliance of Genome Resources | ||||
Meesmann corneal dystrophy 2 | KRT3* | ||||||
megalencephalic leukoencephalopathy with subcortical cysts 2B | HEPACAM* | Hepacam | Alliance of Genome Resources | ||||
Meier-Gorlin syndrome 6 | GMNN* | Gmnn | Alliance of Genome Resources | ||||
melanoma and neural system tumor syndrome | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
metachondromatosis | PTPN11* | Ptpn11 | Alliance of Genome Resources | ||||
metaphyseal dysplasia-maxillary hypoplasia-brachydactyly syndrome | RUNX2* | Runx2 | Alliance of Genome Resources | ||||
metatropic dysplasia | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | KIF11* | Kif11 | Alliance of Genome Resources | ||||
Mitchell syndrome | ACOX1* | Acox1 | Alliance of Genome Resources | ||||
mitochondrial complex V (ATP synthase) deficiency nuclear type 4A | ATP5F1A* | Atp5f1a | Alliance of Genome Resources | ||||
mitochondrial DNA depletion syndrome 12a | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
Miura type epiphyseal chondrodysplasia | NPR2* | Npr2 | Alliance of Genome Resources | ||||
monilethrix | KRT81*, KRT83*, KRT86*, KRT87P | Krt81, Krt83, Krt86, Krt87 | Alliance of Genome Resources | ||||
Muckle-Wells syndrome | NLRP3* | Nlrp3 | Alliance of Genome Resources | ||||
Muckle-Wells syndrome | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
Muir-Torre syndrome | MSH2* | Msh2 | Alliance of Genome Resources | ||||
Muir-Torre syndrome | MLH1* | Mlh1 | Alliance of Genome Resources | ||||
Mullerian aplasia and hyperandrogenism | WNT4* | Wnt4 | Alliance of Genome Resources | ||||
multiple cutaneous and mucosal venous malformations | TEK* | Tek | Alliance of Genome Resources | ||||
multiple endocrine neoplasia type 2A | RET* | Ret | Alliance of Genome Resources | ||||
multiple endocrine neoplasia type 4 | CDKN1B* | Cdkn1b | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 1 | COMP* | Comp | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 2 | COL9A2* | Col9a2 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 3 | COL9A3* | Col9a3 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 6 | COL9A1* | Col9a1 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia with myopia and deafness | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | NOG* | Nog | Alliance of Genome Resources | ||||
multiple synostoses syndrome 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 3 | FGF9* | Fgf9 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 4 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
multiple types of congenital heart defects 6 | GDF1* | Gdf1 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | SLC6A1* | Slc6a1 | Alliance of Genome Resources | ||||
myoclonic-atonic epilepsy | TBC1D24* | Tbc1d24 | Alliance of Genome Resources | ||||
myoclonic dystonia 26 | KCTD17* | Kctd17 | Alliance of Genome Resources | ||||
myoclonic dystonia 34 | KCNN2* | Kcnn2 | Alliance of Genome Resources | ||||
myofibrillar myopathy 3 | MYOT* | Myot | 1 "NOT" model | Alliance of Genome Resources | |||
myofibrillar myopathy 4 | LDB3* | Ldb3 | Alliance of Genome Resources | ||||
myofibrillar myopathy 6 | BAG3* | Bag3 | Alliance of Genome Resources | ||||
Naegeli-Franceschetti-Jadassohn syndrome | KRT14* | Krt14 | Alliance of Genome Resources | ||||
nemaline myopathy 4 | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
nemaline myopathy 5C | TNNT1* | Tnnt1 | Alliance of Genome Resources | ||||
nephrogenic diabetes insipidus type 2 | AQP2* | Aqp2 | Alliance of Genome Resources | ||||
nephrotic syndrome type 4 | WT1* | Wt1 | Alliance of Genome Resources | ||||
NESCAV syndrome | KIF1A* | Kif1a | Alliance of Genome Resources | ||||
neurodegeneration with brain iron accumulation 3 | FTL* | Ftl1, Ftl1-ps2, Ftl2-ps | Alliance of Genome Resources | ||||
neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities | SRSF1* | Srsf1 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with dysmorphic facies and thin corpus callosum | SUPT16H* | Supt16 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with eye movement abnormalities and ataxia | FRMD5* | Frmd5 | Alliance of Genome Resources | ||||
neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | CACNA1C* | Cacna1c | Alliance of Genome Resources | ||||
neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | MEF2C* | Mef2c | Alliance of Genome Resources | ||||
neurodevelopmental disorder with speech impairment and dysmorphic facies | SETD1A* | Setd1a | Alliance of Genome Resources | ||||
neurofibromatosis-Noonan syndrome | NF1* | Nf1 | Alliance of Genome Resources | ||||
neurogenic scapuloperoneal syndrome Kaeser type | DES* | Des | Alliance of Genome Resources | ||||
neuronal ceroid lipofuscinosis 4 | DNAJC5* | Dnajc5 | Alliance of Genome Resources | ||||
neuronal intranuclear inclusion disease | NOTCH2NLC* | ||||||
neurooculocardiogenitourinary syndrome | WDR37* | Wdr37 | Alliance of Genome Resources | ||||
nevoid basal cell carcinoma syndrome 1 | PTCH1* | Ptch1 | Alliance of Genome Resources | ||||
NFIA-related disorder | NFIA* | Nfia | Alliance of Genome Resources | ||||
Nicolaides-Baraitser syndrome | SMARCA2* | Smarca2 | Alliance of Genome Resources | ||||
nonautoimmune hyperthyroidism | TSHR* | Tshr | Alliance of Genome Resources | ||||
nonprogressive cerebellar ataxia with mental retardation | CAMTA1* | Camta1 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 1 | FZD6* | Fzd6 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 3 | PLCD1* | Plcd1 | Alliance of Genome Resources | ||||
nonsyndromic congenital nail disorder 8 | COL7A1* | Col7a1 | Alliance of Genome Resources | ||||
Noonan syndrome 11 | MRAS* | Mras | Alliance of Genome Resources | ||||
Noonan syndrome 12 | RRAS2* | Rras2 | Alliance of Genome Resources | ||||
Noonan syndrome 13 | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
Noonan syndrome 6 | NRAS* | Nras | Alliance of Genome Resources | ||||
Noonan syndrome 7 | BRAF* | Braf | Alliance of Genome Resources | ||||
Noonan syndrome 9 | SOS2* | Sos2 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 1 | PTPN11* | Ptpn11 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 2 | RAF1* | Raf1 | Alliance of Genome Resources | ||||
Noonan syndrome with multiple lentigines 3 | BRAF* | Braf | Alliance of Genome Resources | ||||
oblique facial clefting 1 | SPECC1L* | Specc1l | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 1 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 2 | GIPC1* | Gipc1 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 3 | NOTCH2NLC* | ||||||
oculopharyngodistal myopathy 4 | RILPL1* | Rilpl1 | Alliance of Genome Resources | ||||
omodysplasia 2 | FZD2* | Fzd2 | Alliance of Genome Resources | ||||
optic atrophy 1 | OPA1* | Opa1 | Alliance of Genome Resources | ||||
optic atrophy 1 | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
optic atrophy 10 | RTN4IP1* | Rtn4ip1 | Alliance of Genome Resources | ||||
optic atrophy 12 | AFG3L2* | Afg3l2 | Alliance of Genome Resources | ||||
optic atrophy 3 | OPA3* | Opa3 | Alliance of Genome Resources | ||||
optic atrophy 5 | DNM1L* | Dnm1l | Alliance of Genome Resources | ||||
orofacial cleft 6 | IRF6* | Irf6 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 4 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteoglophonic dysplasia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
otosclerosis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
otosclerosis | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
otosclerosis | VDR* | Vdr | Alliance of Genome Resources | ||||
otosclerosis | AGT* | Agt | Alliance of Genome Resources | ||||
otosclerosis | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
otosclerosis | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
otosclerosis 11 | FOXL1* | Foxl1 | Alliance of Genome Resources | ||||
otospondylomegaepiphyseal dysplasia, autosomal dominant | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
ovarian dysgenesis 8 | ESR2* | Esr2 | Alliance of Genome Resources | ||||
overhydrated hereditary stomatocytosis | RHAG* | Rhag | Alliance of Genome Resources | ||||
pachyonychia congenita | KRT6A*, KRT6B*, KRT6C | Gm5414, Gm5478, Krt6a, Krt6b | 1 model | Alliance of Genome Resources | |||
pachyonychia congenita | KRT17* | Krt17 | 1 model | Alliance of Genome Resources | |||
Paget's disease of bone 2 | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
Paget's disease of bone 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
Paget's disease of bone 6 | ZNF687* | Zfp687 | Alliance of Genome Resources | ||||
palmoplantar keratoderma-deafness syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
pancreatic hypoplasia-diabetes-congenital heart disease syndrome | GATA6* | Gata6 | Alliance of Genome Resources | ||||
PAPA syndrome | PSTPIP1* | Pstpip1 | Alliance of Genome Resources | ||||
paraganglioma | SDHA* | Sdha | Alliance of Genome Resources | ||||
paraganglioma | SDHB* | Sdhb | Alliance of Genome Resources | ||||
paraganglioma | SLC25A11* | Slc25a11 | Alliance of Genome Resources | ||||
paraganglioma | SDHAF2* | Sdhaf2 | Alliance of Genome Resources | ||||
paraganglioma | DLST* | Dlst | Alliance of Genome Resources | ||||
paraganglioma | SDHD* | Sdhd | 3 "NOT" models | Alliance of Genome Resources | |||
paraganglioma | SDHC* | Sdhc | 1 "NOT" model | Alliance of Genome Resources | |||
paramyotonia congenita of Von Eulenburg | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
parastremmatic dwarfism | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Parkinson's disease 22 | CHCHD2*, CHCHD2P9 | Chchd2, Chchd2-ps | Alliance of Genome Resources | ||||
paroxysmal extreme pain disorder | SCN9A* | Scn9a | Alliance of Genome Resources | ||||
paroxysmal nonkinesigenic dyskinesia 3 | KCNMA1* | Kcnma1 | Alliance of Genome Resources | ||||
permanent neonatal diabetes mellitus | GCK* | Gck | Alliance of Genome Resources | ||||
permanent neonatal diabetes mellitus | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
Peroxisome biogenesis disorder 4B | PEX6* | Pex6 | Alliance of Genome Resources | ||||
Perry syndrome | DCTN1* | Dctn1 | Alliance of Genome Resources | ||||
piebaldism | SNAI2* | Snai2 | Alliance of Genome Resources | ||||
pigmented paravenous chorioretinal atrophy | CRB1* | Crb1 | Alliance of Genome Resources | ||||
Pitt-Hopkins syndrome | CNTNAP2* | Cntnap2 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 15 | ACTN1* | Actn1 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 17 | GFI1B* | Gfi1b | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 20 | SLFN14* | Slfn14 | Alliance of Genome Resources | ||||
platelet-type bleeding disorder 3 | GP1BA* | Gp1ba | Alliance of Genome Resources | ||||
polycystic kidney disease 3 | GANAB* | Ganab | Alliance of Genome Resources | ||||
polycystic kidney disease 6 | DNAJB11* | Dnajb11 | Alliance of Genome Resources | ||||
polycystic kidney disease 7 | ALG5* | Alg5 | Alliance of Genome Resources | ||||
polycystic liver disease | GANAB* | Ganab | Alliance of Genome Resources | ||||
polycystic liver disease 1 | PRKCSH* | Prkcsh | Alliance of Genome Resources | ||||
polycystic liver disease 1 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
polycystic liver disease 2 | SEC63* | Sec63 | Alliance of Genome Resources | ||||
polycystic liver disease 3 | ALG8* | Alg8 | Alliance of Genome Resources | ||||
polycystic liver disease 4 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | VSX1* | Vsx1 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 1 | OVOL2* | Ovol2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 2 | COL8A2* | Col8a2 | Alliance of Genome Resources | ||||
posterior polymorphous corneal dystrophy 4 | GRHL2* | Grhl2 | Alliance of Genome Resources | ||||
primary autosomal dominant microcephaly 18 | WDFY3* | Wdfy3 | Alliance of Genome Resources | ||||
primary ciliary dyskinesia 43 | FOXJ1* | Foxj1 | Alliance of Genome Resources | ||||
primary failure of tooth eruption | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
primary ovarian insufficiency 11 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 16 | BNC1* | Bnc1 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 3 | FOXL2* | Foxl2 | Alliance of Genome Resources | ||||
primary ovarian insufficiency 5 | NOBOX* | Nobox | Alliance of Genome Resources | ||||
primary ovarian insufficiency 6 | FIGLA* | Figla | Alliance of Genome Resources | ||||
primary ovarian insufficiency 7 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 1 | PRKAR1A* | Prkar1a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 2 | PDE11A* | Pde11a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 4 | PRKACA* | Prkaca | Alliance of Genome Resources | ||||
progeria | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
progressive familial heart block type IB | TRPM4* | Trpm4 | Alliance of Genome Resources | ||||
progressive myoclonus epilepsy 7 | KCNC1* | Kcnc1 | Alliance of Genome Resources | ||||
progressive osseous heteroplasia | GNAS* | Gnas | Alliance of Genome Resources | ||||
protein C deficiency | PROC* | Proc | Alliance of Genome Resources | ||||
proteosome-associated autoinflammatory syndrome 2 | POMP* | Pomp | Alliance of Genome Resources | ||||
proximal symphalangism | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 1 | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
pulmonary venoocclusive disease 1 | BMPR2* | Bmpr2 | Alliance of Genome Resources | ||||
Rapp-Hodgkin syndrome | TP63* | Trp63 | Alliance of Genome Resources | ||||
renal hypomagnesemia 7, with or without dilated cardiomyopathy | RRAGD* | Rragd | Alliance of Genome Resources | ||||
retinal arterial tortuosity | COL4A1* | Col4a1 | Alliance of Genome Resources | ||||
retinal macular dystrophy 2 | PROM1* | Prom1 | Alliance of Genome Resources | ||||
retinal macular dystrophy 4 | CLEC3B* | Clec3b | Alliance of Genome Resources | ||||
retinal vasculopathy with cerebral leukodystrophy | TREX1* | Trex1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 10 | IMPDH1* | Impdh1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 27 | NRL* | Nrl | Alliance of Genome Resources | ||||
retinitis pigmentosa 33 | SNRNP200* | Snrnp200 | Alliance of Genome Resources | ||||
retinitis pigmentosa 35 | SEMA4A* | Sema4a | Alliance of Genome Resources | ||||
retinitis pigmentosa 37 | NR2E3* | Nr2e3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 42 | KLHL7* | Klhl7 | Alliance of Genome Resources | ||||
retinitis pigmentosa 60 | PRPF6* | Prpf6 | Alliance of Genome Resources | ||||
retinitis pigmentosa 7 | ROM1* | Rom1 | Alliance of Genome Resources | ||||
retinitis pigmentosa 70 | PRPF4* | Prpf4 | Alliance of Genome Resources | ||||
retinitis pigmentosa 83 | ARL3* | Arl3 | Alliance of Genome Resources | ||||
retinitis pigmentosa 87 | RPE65* | Rpe65 | Alliance of Genome Resources | ||||
retinitis pigmentosa 89 | KIF3B* | Kif3b | Alliance of Genome Resources | ||||
retinitis pigmentosa 9 | RP9* | Rp9 | Alliance of Genome Resources | ||||
Revesz syndrome | TINF2* | Tinf2 | Alliance of Genome Resources | ||||
ring dermoid of cornea | PITX2* | Pitx2 | Alliance of Genome Resources | ||||
Rubinstein-Taybi syndrome | EP300* | Ep300 | Alliance of Genome Resources | ||||
SADDAN | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
Saethre-Chotzen syndrome | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
Saul-Wilson syndrome | COG4* | Cog4 | Alliance of Genome Resources | ||||
scapuloperoneal spinal muscular atrophy | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Schinzel Giedion syndrome | SETBP1* | Setbp1 | Alliance of Genome Resources | ||||
schizophrenia 15 | SHANK3* | Shank3 | Alliance of Genome Resources | ||||
schizophrenia 4 | PRODH* | Prodh | Alliance of Genome Resources | ||||
schizophrenia 6 | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
Schopf-Schulz-Passarge syndrome | WNT10A* | Wnt10a | Alliance of Genome Resources | ||||
Schuurs-Hoeijmakers Syndrome | PACS1* | Pacs1 | Alliance of Genome Resources | ||||
schwannomatosis | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
schwannomatosis | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
schwannomatosis 1 | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
schwannomatosis 2 | LZTR1* | Lztr1 | Alliance of Genome Resources | ||||
selective pituitary thyroid hormone resistance | THRB* | Thrb | Alliance of Genome Resources | ||||
sepiapterin reductase deficiency | SPR* | Spr | Alliance of Genome Resources | ||||
severe congenital neutropenia 1 | ELANE* | Elane | Alliance of Genome Resources | ||||
severe congenital neutropenia 2 | GFI1* | Gfi1 | Alliance of Genome Resources | ||||
severe congenital neutropenia 8 | SRP54* | Srp54a, Srp54b, Srp54c | Alliance of Genome Resources | ||||
Sifrim-Hitz-Weiss syndrome | CHD4* | Chd4 | Alliance of Genome Resources | ||||
snowflake vitreoretinal degeneration | KCNJ13* | Kcnj13 | Alliance of Genome Resources | ||||
solitary median maxillary central incisor | SHH* | Shh | Alliance of Genome Resources | ||||
Sotos syndrome 1 | NSD1* | Nsd1 | Alliance of Genome Resources | ||||
spastic ataxia 1 | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
speech-language disorder-1 | FOXP2* | Foxp2 | Alliance of Genome Resources | ||||
spermatogenic failure 10 | SEPTIN12* | Septin12 | Alliance of Genome Resources | ||||
spermatogenic failure 11 | KLHL10* | Klhl10 | Alliance of Genome Resources | ||||
spermatogenic failure 12 | NANOS1* | Nanos1 | Alliance of Genome Resources | ||||
spermatogenic failure 2 | MSH4* | Msh4 | Alliance of Genome Resources | ||||
spermatogenic failure 3 | SLC26A8* | Slc26a8 | Alliance of Genome Resources | ||||
spermatogenic failure 3 | SRSF6* | Srsf6 | Alliance of Genome Resources | ||||
spermatogenic failure 32 | SOHLH1* | Sohlh1 | Alliance of Genome Resources | ||||
spermatogenic failure 36 | PPP2R3C* | Ppp2r3c | Alliance of Genome Resources | ||||
spermatogenic failure 4 | SYCP3* | Gm773, Sycp3 | Alliance of Genome Resources | ||||
spermatogenic failure 8 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
spinal muscular atrophy, Jokela type | CHCHD10* | Chchd10 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 1 | DYNC1H1* | Dync1h1 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2A | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | BICD2* | Bicd2 | Alliance of Genome Resources | ||||
spinal muscular atrophy with lower extremity predominant 2B | ND6* | mt-Nd6 | Alliance of Genome Resources | ||||
spinal neurofibromatosis | NF1* | Nf1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 44 | GRM1* | Grm1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 45 | FAT2* | Fat2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia 46 | PLD3* | Pld3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 10 | ATXN10* | Atxn10 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 11 | TTBK2* | Ttbk2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 12 | PPP2R2B* | Ppp2r2b | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 13 | KCNC3* | Kcnc3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 15 | ITPR1* | Itpr1 | 2 models | Alliance of Genome Resources | |||
spinocerebellar ataxia type 19/22 | KCND3* | Kcnd3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 21 | TMEM240* | Tmem240 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 23 | PDYN* | Pdyn | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 25 | PNPT1* | Pnpt1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 26 | EEF2* | Eef2 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 29 | ITPR1* | Itpr1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 31 | BEAN1* | Bean1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 34 | ELOVL4* | Elovl4 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 35 | TGM6* | Tgm6 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 36 | NOP56* | Nop56 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 37 | DAB1* | Dab1 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 38 | ELOVL5* | Elovl5 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 4 | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 40 | CCDC88C* | Ccdc88c | Alliance of Genome Resources | ||||
spinocerebellar ataxia type 8 | ATXN8OS* | ||||||
spinocerebellar ataxia type 8 | ATXN8* | ||||||
split hand-foot malformation 4 | TP63* | Trp63 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Missouri type | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Strudwick type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 2 | KIF22* | Kif22 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Kimberley type | ACAN* | Acan | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Maroteaux type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Nishimura type | MIR140* | Mir140 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Stanescu type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia corner fracture type | FN1* | Fn1 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Kozlowski type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondyloperipheral dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
steatocystoma multiplex | KRT17* | Krt17 | Alliance of Genome Resources | ||||
Stickler syndrome 1 | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
Stickler syndrome 2 | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
stiff skin syndrome | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
Sweeney-Cox syndrome | TWIST1* | Twist1 | Alliance of Genome Resources | ||||
syndactyly-telecanthus-anogenital and renal malformations syndrome | CCNQ* | Ccnq | Alliance of Genome Resources | ||||
syndactyly type 1 | IHH* | Ihh | Alliance of Genome Resources | ||||
syndactyly type 3 | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
syndactyly type 4 | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
syndactyly type 4 | SHH* | Shh | Alliance of Genome Resources | ||||
syndactyly type 5 | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
syndromic microphthalmia 3 | SOX2* | Sox2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 5 | OTX2* | Otx2 | Alliance of Genome Resources | ||||
syndromic microphthalmia 6 | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
tarsal-carpal coalition syndrome | NOG* | Nog | Alliance of Genome Resources | ||||
Tatton-Brown-Rahman syndrome | DNMT3A* | Dnmt3a | Alliance of Genome Resources | ||||
terminal osseous dysplasia | FLNA* | Flna | Alliance of Genome Resources | ||||
Thiel-Behnke corneal dystrophy | TGFBI* | Tgfbi | Alliance of Genome Resources | ||||
Thomsen disease | CLCN1* | Clcn1 | Alliance of Genome Resources | ||||
thrombophilia due to activated protein C resistance | PROC* | Proc | Alliance of Genome Resources | ||||
thrombophilia due to activated protein C resistance | F5* | F5 | Alliance of Genome Resources | ||||
thrombophilia due to HRG deficiency | HRG* | Hrg | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | F2* | F2 | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | HABP2* | Habp2 | Alliance of Genome Resources | ||||
thrombophilia due to thrombin defect | F13A1* | F13a1 | Alliance of Genome Resources | ||||
torsion dystonia 4 | TUBB4A* | Tubb4a | Alliance of Genome Resources | ||||
Townes-Brocks syndrome | DACT1* | Dact1 | Alliance of Genome Resources | ||||
Treacher Collins syndrome 1 | TCOF1* | Tcof1 | Alliance of Genome Resources | ||||
Treacher Collins syndrome 2 | POLR1D* | Polr1d | Alliance of Genome Resources | ||||
Treacher Collins syndrome 3 | POLR1C* | Polr1c | Alliance of Genome Resources | ||||
Treacher Collins syndrome 4 | POLR1B* | Polr1b | Alliance of Genome Resources | ||||
trichodontoosseous syndrome | DLX3* | Dlx3 | Alliance of Genome Resources | ||||
trichorhinophalangeal syndrome type III | TRPS1* | Trps1 | Alliance of Genome Resources | ||||
tuberous sclerosis 1 | TSC1* | Tsc1 | Alliance of Genome Resources | ||||
tuberous sclerosis 2 | TSC2* | Tsc2 | Alliance of Genome Resources | ||||
tuberous sclerosis 2 | IFNG* | Ifng | Alliance of Genome Resources | ||||
tubular aggregate myopathy 2 | ORAI1* | Orai1 | Alliance of Genome Resources | ||||
type 1 diabetes mellitus 2 | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1A | COL6A1* | Col6a1 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1B | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1C | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 2 | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
uveal coloboma-cleft lip and palate-intellectual disability | YAP1* | Yap1 | Alliance of Genome Resources | ||||
vertebral anomalies and variable endocrine and T-cell dysfunction | TBX2* | Tbx2 | Alliance of Genome Resources | ||||
vertebral hypersegmentation and orofacial anomalies | GDF11* | Gdf11 | Alliance of Genome Resources | ||||
vestibular schwannomatosis | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
vestibular schwannomatosis | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
Vissers-Bodmer syndrome | CNOT1* | Cnot1 | Alliance of Genome Resources | ||||
Vohwinkel syndrome | GJB2* | Gjb2 | Alliance of Genome Resources | ||||
Vulto-van Silfout-de Vries syndrome | DEAF1* | Deaf1 | Alliance of Genome Resources | ||||
Waardenburg syndrome | EDN3* | Edn3 | Alliance of Genome Resources | ||||
Waardenburg syndrome | PAX3* | Pax3 | Alliance of Genome Resources | ||||
Waardenburg syndrome | EDNRB* | Ednrb | Alliance of Genome Resources | ||||
Waardenburg syndrome | KITLG* | Kitl | Alliance of Genome Resources | ||||
Waardenburg syndrome | MITF* | Mitf | Alliance of Genome Resources | ||||
Waardenburg syndrome type 2E | SOX10* | Sox10 | Alliance of Genome Resources | ||||
Waardenburg syndrome type 3 | PAX3* | Pax3 | 5 "NOT" models | Alliance of Genome Resources | |||
Watson syndrome | NF1* | Nf1 | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC* | Evc | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC2* | Evc2 | Alliance of Genome Resources | ||||
white sponge nevus 1 | KRT4* | Krt4 | Alliance of Genome Resources | ||||
white sponge nevus 2 | KRT13* | Krt13 | Alliance of Genome Resources | ||||
White-Sutton syndrome | POGZ* | Pogz | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | BUD23* | Bud23 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | DNAJC30* | Dnajc30 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | ELN* | Eln | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FKBP6* | Fkbp6 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | FZD3* | Fzd3 | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | LAT2* | Lat2 | 2 models | Alliance of Genome Resources | |||
Williams-Beuren syndrome | NCF1*, NCF1B, NCF1C | Ncf1 | Alliance of Genome Resources | ||||
Williams-Beuren syndrome | RCC1L* | Rcc1l | Alliance of Genome Resources | ||||
Worth syndrome | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
ZTTK syndrome | SON* | Son | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
abdominal obesity-metabolic syndrome | Tg(RP11-578M14)5Mkru | 1 model | |
abdominal obesity-metabolic syndrome 1 | Tg(Fabp4-Hsd11b1)7Jesf | 1 model | |
abdominal obesity-metabolic syndrome 1 | Tg(Fabp4-ENPP1)#Naba | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Lmnb1)1Yfu | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-LMNB1)1108Qsp | 1 model | |
adult-onset autosomal dominant demyelinating leukodystrophy | Tg(Plp1-Lmnb1)#Yfu | 1 model | |
advanced sleep phase syndrome 1 | Tg(PER2*S662G)867Ljp | 1 model | |
advanced sleep phase syndrome 2 | Tg(CSNK1D*,-EGFP)816Yfu | 1 model | |
advanced sleep phase syndrome 2 | Tg(CSNK1D*,-EGFP)827Yfu | 1 model | |
age related macular degeneration 1 | Tg(APOB)1102Sgy | 1 model | |
Alexander disease | Tg(Gfap-GFAP*R239H)60TMIke | 1 model | |
Alexander disease | Tg(GFAP)10Mes | 3 models | |
Alexander disease | Tg(GFAP)7Mes | 1 model | |
Alzheimer's disease 3 | Tg(PSEN1H163R)G9Btla | 1 model | |
Alzheimer's disease 3 | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
Alzheimer's disease 3 | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | 1 model | |
Alzheimer's disease 3 | Tg(PSEN1dE9)S9Dbo | 4 models | |
Alzheimer's disease 4 | Tg(APP695)3Dbo | 3 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)#Deng | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)#Roos | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)641Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R/EYFP)737Alho | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Sod1*G86R)M1Jwg | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)1Gur | 6 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)2Gur | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G93A)dl1Gur | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G127X)716Mrkl | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)#Maw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)IAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R)LAra | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)58Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*H46R*H48Q)139Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*L126Z)45Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-DCTN1*G59S)M2Pcw | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-Sncg)HvP36Putt | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Thy1-SOD1*G93A)T3Hgrd | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Myl1-SOD1*G93A)#Amu | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(NEFH)200Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(NFH)120Jpj | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-Immt/SOD1*G93A)7Gmnf | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)125Dbo | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)D-14Dbo | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*)DF7Yaw | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)1Dwc | 2 models | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)9Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)29Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)42Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G37R)106Dpr | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)74Dwc | 1 model | |
amyotrophic lateral sclerosis type 1 | Tg(SOD1*G85R)148Dwc | 1 model | |
arrhythmogenic right ventricular dysplasia 12 | Tg(Myh6-JUP*)1Dpju | 1 model | |
arrhythmogenic right ventricular dysplasia 12 | Tg(Myh6-Jup*)1Ajm | 2 models | |
arrhythmogenic right ventricular dysplasia 9 | Tg(Myh6-Pkp2*/mRuby)4Rbrug | 2 models | |
arrhythmogenic right ventricular dysplasia 9 | Tg(Myh6-Pkp2*/mRuby)5Rbrug | 2 models | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diaph3)771Lesp | 1 model | |
autosomal dominant auditory neuropathy 1 | Tg(CAG-Diap3)924Lesp | 1 model | |
autosomal dominant hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
autosomal dominant keratitis-ichthyosis-deafness syndrome | Tg(tetO-GJB2*G45E,-EGFP)#Tww | 1 model | |
autosomal dominant limb-girdle muscular dystrophy type 1 | Tg(Ckm-DNAJB6_ib*F93L)#Ccwe | 1 model | |
autosomal dominant nocturnal frontal lobe epilepsy 3 | Tg(tetO-Chrnb2*V287L)H3Gica | 1 model | |
autosomal dominant polycystic kidney disease | Tg(HBB-Myc)#Cos | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)AHjal | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(Kera-PITX2*A)BHjal | 1 model | |
Axenfeld-Rieger syndrome type 1 | Tg(KRT14-Hmgn2)#Baam | 1 model | |
CADASIL 1 | Tg(Notch3*R169C)88Bbb | 1 model | |
Carney complex | Tg(tetO-Prkar1a*x2as)1Stra | 1 model | |
cataract 2 multiple types | Tg(CRYBB1-CRYGC*)#Jfhe | 1 model | |
cataract 30 | Tg(Vim*R113C)1Tmm | 1 model | |
cataract 5 multiple types | Tg(Hsf4/EGFP)N7Spbh | 1 model | |
Charcot-Marie-Tooth disease axonal type 2F | Tg(Thy1-HSPB1*S135F)#Lvdb | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(tetO/CMV-Pmp22)JP18Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)My41Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C61Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C22Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C3Fbas | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)247Ueli | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.4Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)30Mes | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)31Mes | 2 models | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.1Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.2Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1C | Tg(CMV-LITAF*W116G)#Lli | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L51Ugfm | 2 models | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L87Ugfm | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(tetO-NEFL)173.2Jpj | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(NEFL*E397K)#Milg | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)32Mes | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)33Mes | 1 model | |
congenital myasthenic syndrome 3A | Tg(Ckm-Chrnd*S262T)40Cgz | 1 model | |
congenital myasthenic syndrome 4A | Tg(Ckm-Chrne*L269F)5Cgz | 1 model | |
congenital stationary night blindness autosomal dominant 1 | Tg(Rho*G90D*A337V)202Sie | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)124Dbo | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Prnp-ATN1)150Dbo | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)3Tx | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(ATN1*)Q129Stsu | 1 model | |
dentatorubral-pallidoluysian atrophy | Tg(Eno2-ATN1)14Tx | 1 model | |
DiGeorge syndrome | Del(16Dgcr2-Hira)1Rak | 1 model | |
DiGeorge syndrome | Del(16Dgcr2-Hira)3Aam | 1 model | |
DiGeorge syndrome | Del(16Es2el-Ufd1l)217Bld | 1 model | |
dilated cardiomyopathy 1A | Tg(Myh6-LMNA*E82K)35Lizh | 1 model | |
dilated cardiomyopathy 1C | Tg(Myh6-LDB3*S196L)93Mva | 1 model | |
dilated cardiomyopathy 1D | Tg(Myh6-TNNT2*R141W)#Lian | 1 model | |
dilated cardiomyopathy 1D | Tg(Myh6-TNNT2*R141W)#Ajm | 1 model | |
dilated cardiomyopathy 1E | Tg(Myh6*/tetO-SCN5A*F1759A)#Marx | 1 model | |
dilated cardiomyopathy 1R | Tg(Myh6-ACTC1*E361G)361.20Sbm | 1 model | |
dilated cardiomyopathy 1R | Tg(Myh6-Actc1*R312H)307Iko | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*D230N)HJcf | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*E54K)30Dfw | 1 model | |
dilated cardiomyopathy 1Y | Tg(Myh6-Tpm1*E54K)67Dfw | 1 model | |
familial cold autoinflammatory syndrome 4 | Tg(Cd74-Nlrc4*)1Kyas | 1 model | |
familial encephalopathy with neuroserpin inclusion bodies | Tg(Thy1-SERPINI1*G392E)333Icka | 2 models | |
familial temporal lobe epilepsy 1 | Tg(Lgi1*)#Mpan | 1 model | |
Feingold syndrome | Mirc1 | 1 model | |
fibrodysplasia ossificans progressiva | Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis | 1 model | |
fibrodysplasia ossificans progressiva | Tg(Eno2-Bmp4)3Jake | 1 model | |
Finnish type amyloidosis | Tg(Ckm-GSN*D187N)AJewe | 2 models | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6)F419Walz | 1 model | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*P111Q)F615Walz | 1 model | |
focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*E896K)F75aWalz | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Thy1-TARDBP*)BOddo | 2 models | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*G348C)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP*A315T)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(TARDBP)#Jpj | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Prnp-TARDBP)3cPtrc | 1 model | |
Grn-related frontotemporal lobar degeneration with Tdp43 inclusions | Tg(Camk2a-Tardbp)#Ckjs | 1 model | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)382Wha | 1 model | |
hyperekplexia 1 | Tg(Thy1-GLRA1*R271Q)300Wha | 1 model | |
hyper IgE recurrent infection syndrome 1 | Tg(Stat3*)9199Alau | 1 model | |
idiopathic pulmonary fibrosis | Tg(H2-K-Fosl2,-EGFP)13Wag | 1 model | |
idiopathic pulmonary fibrosis | Tg(SFTPC-Tnf)2Pva | 1 model | |
juvenile polyposis syndrome | Tg(CAG-Bmpr1a*,-lacZ)1Nobs | 1 model | |
long QT syndrome 1 | Tg(Myh6-KCNQ1_i2)H02Desc | 1 model | |
long QT syndrome 1 | Tg(Myh6-KCNQ1_i2)H05Desc | 1 model | |
Machado-Joseph disease | Tg(CMV-ATXN3*135Q)CPama | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)NLS.28Olri | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*148Q)148.19Olri | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*79Q)#Hlw | 1 model | |
Machado-Joseph disease | Tg(Prnp-ATXN3*70Q)70.61Olri | 1 model | |
Machado-Joseph disease | Tg(Pcp2-ATXN3*69Q)bHirai | 1 model | |
Machado-Joseph disease | Tg(Htt-ATXN3*148Q)3746Thsc | 1 model | |
Machado-Joseph disease | Tg(CMV-ATXN3*94Q)94Pama | 2 models | |
Machado-Joseph disease | Tg(ATXN3*)84.2Cce | 3 models | |
Machado-Joseph disease | Tg(ATXN3*)67.2Cce | 2 models | |
Marsili syndrome | Tg(Zfhx2*R1907K)#Jcox | 1 model | |
maturity-onset diabetes of the young type 3 | Tg(Ins2-Hnf1a)#Cbw | 1 model | |
maturity-onset diabetes of the young type 3 | Tg(Ins2-TCF1*P291)2Kya | 1 model | |
myofibrillar myopathy 1 | Tg(Myh6-Des*)641Rbns | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-Cryab*R120G)708Rbns | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-CRYAB*R120G)7302Ijb | 1 model | |
myofibrillar myopathy 3 | Tg(ACTA1-MYOT*T57I)71Mah | 1 model | |
myofibrillar myopathy 6 | Tg(Myh6-BAG3*P209L)#Mswi | 1 model | |
neurodegeneration with brain iron accumulation 3 | Tg(PGK1-FTL*)#Sle | 1 model | |
neurodegeneration with brain iron accumulation 3 | Tg(Prnp-FTL*)4Ruvi | 1 model | |
Noonan syndrome 1 | Tg(CAG-cat,-Ptpn11*Q97R)1Rbns | 2 models | |
Noonan syndrome 1 | Tg(Myh7-Ptpn11*Q79R)11Rbns | 1 model | |
Noonan syndrome with multiple lentigines | Tg(Myh7-Ptpn11*Q510E)#Krnz | 1 model | |
Noonan syndrome with multiple lentigines | Tg(CAG-cat,-Ptpn11*Q510E)#Krnz | 1 model | |
osteogenesis imperfecta type 1 | Tg(COL1A1)73Prc | 1 model | |
osteogenesis imperfecta type 5 | Tg(Col1a1-Ifitm5*)1Brle | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*A30P)18Pjk | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA)4Ema | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*E57K)16Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA*A53T)8Ema | 1 model | |
Parkinson's disease 1 | Tg(PDGFB-SNCA/EGFP)78Ema | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)25Mkle | 1 model | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)83Vle | 2 models | |
Parkinson's disease 1 | Tg(Prnp-SNCA*A53T)AAub | 2 models | |
Parkinson's disease 1 | Tg(SNCA)ARyot | 1 model | |
Parkinson's disease 1 | Tg(SNCA*E46K)3Elan | 1 model | |
Parkinson's disease 1 | Tg(Snca-SNCA)#Galt | 1 model | |
Parkinson's disease 1 | Tg(Th-SNCA*)1702Yosh | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA)61Ema | 1 model | |
Parkinson's disease 1 | Tg(THY1-SNCA*A53T)M53Sud | 1 model | |
Parkinson's disease 1 | Tg(Thy1-SNCA*)#Ztzh | 1 model | |
Parkinson's disease 4 | Tg(Thy1-Snca)1S13Putt | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*G2019S)32Hlw | 1 model | |
Parkinson's disease 8 | Tg(Lrrk2*G2019S)2Yue | 1 model | |
Parkinson's disease 8 | Tg(PDGFB-LRRK2*R1441C)31Hlw | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)704Ljp | 1 model | |
paroxysmal nonkinesigenic dyskinesia 1 | Tg(Pnkd*A7V*A9V,-DsRed)671Ljp | 1 model | |
PCWH syndrome | Tg(Venus/SOX10*)55Kein | 2 models | |
Perry syndrome | Tg(Thy1-DCTN1*G71A)#Ytsu | 1 model | |
polycystic kidney disease 1 | Tg(Pkd1*)39Mtru | 2 models | |
polycystic kidney disease 2 | Tg(CAG-PKD2)#Hwl | 1 model | |
progeria | Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer | 1 model | |
progeria | Tg(LMNA*G608G)HClns | 1 model | |
pseudoachondroplasia | Tg(Col2a1-rtTA,tetO-COMP*)2Jath | 1 model | |
retinitis pigmentosa 4 | Tg(Rho)1Wbae | 1 model | |
retinitis pigmentosa 4 | Tg(RHO-P23H)DTpd | 1 model | |
retinitis pigmentosa 4 | Tg(RHO*P347S)A1Tili | 3 models | |
rippling muscle disease 2 | Tg(Ckmm-Cav3)1Ysu | 1 model | |
spinocerebellar ataxia type 1 | Tg(tetO-ATXN1*82Q)#Horr | 1 model | |
spinocerebellar ataxia type 1 | Tg(Pcp2-ATXN1*82Q)5Horr | 1 model | |
spinocerebellar ataxia type 10 | Tg(Prnp-lacZ/ATXN10*)#Teas | 1 model | |
spinocerebellar ataxia type 14 | Tg(tetO-PRKCG*S361G,-GFP)3Jpka | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-27Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Pcp2-TBP*)69Hmhl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)71-16Xjl | 1 model | |
spinocerebellar ataxia type 17 | Tg(Prnp-TBP*)105Xjl | 1 model | |
spinocerebellar ataxia type 2 | Tg(Pcp2-ATXN2*127Q)#Plt | 1 model | |
spinocerebellar ataxia type 2 | Tg(ATXN2*72Q)#Plt | 1 model | |
spinocerebellar ataxia type 5 | Tg(tetO-SPTBN2*)#Lpwr | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2542Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(RHO-SCA7)R7EJman | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)6076Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(Prnp-ATXN7*92Q)1963Als | 1 model | |
spinocerebellar ataxia type 7 | Tg(Pcp2-SCA7)P7EJman | 1 model | |
spinocerebellar ataxia type 7 | Tg(GFAP-ATXN7*92Q)2521Als | 1 model | |
split hand-foot malformation 1 | Del(6Dlx6-Dlx5)1Tlu | 1 model | |
spondyloepiphyseal dysplasia congenita | Tg(Col2a1*R789C)#Waho | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)1Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)3Kzh | 1 model | |
Stargardt disease | Tg(RBP3-ELOVL4*)2Kzh | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)2Nush | 1 model | |
torsion dystonia 1 | Tg(Eno2-TOR1A*)13Shas | 1 model | |
torsion dystonia 1 | Tg(CMV-TOR1A*)1Nush | 1 model | |
transthyretin amyloidosis | Tg(TTR-V30M)15Imeg | 3 models | |
transthyretin amyloidosis | Tg(TTR)#Jbux | 1 model | |
tuberous sclerosis | Tg(CMV-Tsc2*)1Arbi | 1 model | |
tuberous sclerosis | Tg(CAG-Mtor*)#Atai | 1 model | |
type 1 diabetes mellitus 2 | Tg(Ins-Igf2)1Fbos | 3 models | |
Williams-Beuren syndrome | Del(5Gtf2i-Fkbp6)1Vcam | 1 model |